Pathology important questions with answers

I'll need a bit more context to give you the most useful set of questions. Let me ask quickly:

Asking for Preferences

What is your level/exam? · Which area of pathology do you want covered?

I'll now pull content from the medical library across all major pathology topics for MBBS level.

Reading File

Now let me search the medical library across all major pathology topics in parallel.

Finding Sources

Let me try broader searches to find pathology books in the library.

Finding Sources

Robbins & Kumar is available. Let me search the TOC and key paragraphs across major pathology topics.

Finding Sources

I now have excellent source material from Robbins & Kumar. Let me read the key sections to compile detailed answers.

Reading File

Excellent - I now have rich content from Robbins. I have enough to compile a thorough, well-organized Q&A set covering all major MBBS pathology topics. Let me now compile the final answer.Here is a comprehensive set of important pathology questions and answers for MBBS (1st/2nd year), covering all major topics from Robbins & Kumar Basic Pathology and Robbins Pathologic Basis of Disease.

Pathology - Important Questions & Answers (MBBS)

UNIT 1: CELL INJURY, DEATH & ADAPTATIONS

Q1. Define etiology and pathogenesis. How are they different?

A: Etiology is the origin/cause of a disease, including underlying causes and modifying factors (the "why"). Pathogenesis refers to the steps in the development of a disease - from the initial etiologic trigger through the cellular and molecular changes that produce the specific functional and structural abnormalities (the "how"). For example, in atherosclerosis, the etiology includes hyperlipidemia and hypertension; the pathogenesis involves endothelial injury, lipid accumulation, and foam cell formation.

Robbins & Kumar Basic Pathology

Q2. What is homeostasis? How do cells respond to stress?

A: Homeostasis is the steady state that cells actively maintain by adjusting their structure and function to accommodate changing demands and extracellular stresses. When cells encounter physiologic stresses or injurious stimuli, they can:

Adapt - achieve a new steady state, preserving viability (e.g., hypertrophy, hyperplasia, atrophy, metaplasia)
Undergo reversible injury - if adaptive capability is exceeded but stimulus is mild/brief
Die (irreversible injury) - if stress is severe or persistent

Robbins & Kumar Basic Pathology

Q3. Enumerate the causes of cell injury.

A: Major causes:

Hypoxia and ischemia - most common; deprive cells of oxygen (needed for ATP generation)
Physical agents - trauma, heat/cold, radiation, electrical injury
Chemical agents and drugs - toxins, poisons, drugs (e.g., carbon tetrachloride)
Infectious agents - bacteria, viruses, fungi, parasites
Immunologic reactions - autoimmune diseases, hypersensitivity reactions
Genetic derangements - mutations causing enzyme defects, structural protein abnormalities
Nutritional imbalances - protein-calorie malnutrition, vitamin deficiencies, excess (obesity)

Robbins & Kumar Basic Pathology

Q4. What are the mechanisms of cell injury? Name the key biochemical targets.

A: Four key biochemical targets are affected in cell injury:

Mitochondria - impaired oxidative phosphorylation → reduced ATP → membrane pump failure → cellular swelling
Cellular membranes - damage to plasma and organelle membranes → loss of ion gradients, leakage of enzymes
Nucleus (DNA) - strand breaks from free radicals or toxins → if not repaired, cell undergoes apoptosis
Endoplasmic reticulum (ER) - accumulation of misfolded proteins triggers the unfolded protein response (UPR); severe ER stress triggers apoptosis

Irreversible injury occurs when mitochondrial damage is massive and lysosomal membranes rupture.

Robbins & Kumar Basic Pathology

Q5. What is the difference between reversible and irreversible cell injury?

Feature	Reversible Injury	Irreversible Injury
Mitochondria	Swelling, loss of phospholipids	Vacuolation, large amorphous densities
Plasma membrane	Blebbing, blunting of microvilli	Rupture
Nucleus	Chromatin clumping	Pyknosis, karyorrhexis, karyolysis
Lysosomes	Intact	Rupture, enzymatic digestion
Cell fate	Returns to normal	Necrosis or apoptosis

Key morphologic features of reversible injury: cellular swelling (most common), fatty change (steatosis), cytoplasmic vacuolization.

Robbins & Kumar Basic Pathology

Q6. Compare necrosis and apoptosis.

Feature	Necrosis	Apoptosis
Cause	Ischemia, toxins, infections (pathologic)	Physiologic or pathologic
Cell size	Enlarged (swelling)	Reduced (shrinkage)
Nucleus	Pyknosis → karyorrhexis → karyolysis	Fragmentation into nucleosome-sized pieces
Plasma membrane	Disrupted	Intact, blebbing
Cell contents	Leaked - causes inflammation	Packaged in apoptotic bodies, no inflammation
Adjacent inflammation	Yes (prominent)	No
Examples	MI, ischemic stroke	Embryogenesis, immune cell deletion, hormone-deprived tissue

Importantly, these two pathways may overlap - apoptosis can progress to necrosis ("secondary necrosis").

Robbins & Kumar Basic Pathology, Robbins Pathologic Basis of Disease

Q7. What are the morphologic patterns of necrosis? Give examples.

Pattern	Mechanism	Example
Coagulative	Protein denaturation preserves cell outlines	Myocardial infarction, kidney infarction
Liquefactive	Enzymatic digestion liquefies tissue	Brain infarction, abscess
Caseous	Combination: cheese-like, structureless	Tuberculosis (TB)
Fat necrosis	Lipase digestion of fat	Acute pancreatitis, breast trauma
Fibrinoid	Immune complexes + fibrin deposition in vessel walls	Vasculitis, malignant hypertension
Gangrenous	Usually coagulative; "wet" gangrene has superimposed liquefaction	Diabetic foot, bowel infarction

Robbins & Kumar Basic Pathology

Q8. What are the cellular adaptations to stress? Define each.

Hypertrophy - increase in cell size (not number). Occurs in non-dividing cells (cardiac muscle, skeletal muscle). E.g., cardiac hypertrophy in hypertension.
Hyperplasia - increase in cell number. Occurs in dividing cells. E.g., endometrial hyperplasia with estrogen excess.
Atrophy - decrease in cell size/number. E.g., muscle wasting from disuse, denervation.
Metaplasia - replacement of one differentiated cell type by another, usually more resistant type. E.g., squamous metaplasia of bronchial epithelium in smokers (columnar → squamous). Reversible but predisposes to malignancy.
Dysplasia - disordered growth; considered pre-malignant. E.g., cervical dysplasia (CIN).

Robbins & Kumar Basic Pathology

Q9. What is intracellular accumulation? Give examples.

A: When cells are incapable of metabolizing or exporting a substance, it accumulates. Types:

Steatosis (fatty change) - triglycerides in liver cells; caused by alcohol, obesity, diabetes, toxins
Cholesterol accumulation - atherosclerosis, xanthomas (foam cells)
Protein accumulation - Russell bodies in plasma cells (immunoglobulins)
Hyaline change - intracellular pink, glassy material (e.g., alcoholic hyaline/Mallory bodies in hepatocytes)
Glycogen accumulation - glycogen storage diseases (e.g., von Gierke disease - glucose-6-phosphatase deficiency)
Pigments - lipofuscin ("wear and tear" pigment, brown), melanin, hemosiderin (iron), carbon (anthracosis)
Pathologic calcification - dystrophic (in dead tissue, normal serum calcium) vs. metastatic (in normal tissue, elevated serum calcium)

Robbins & Kumar Basic Pathology

UNIT 2: INFLAMMATION & REPAIR

Q10. Define inflammation. What are its cardinal signs?

A: Inflammation is a response of vascularized tissues to infections, tissue damage, and other injurious stimuli. Its purpose is to eliminate the cause of cell injury, clear necrotic debris, and initiate tissue repair.

Cardinal signs (Celsus/Virchow):

Rubor (redness) - increased blood flow
Calor (heat) - increased blood flow
Tumor (swelling) - increased vascular permeability
Dolor (pain) - prostaglandins and bradykinin
Functio laesa (loss of function) - Virchow's addition

Robbins & Kumar Basic Pathology

Q11. Compare acute and chronic inflammation.

Feature	Acute	Chronic
Onset	Fast (minutes to days)	Slow (weeks to months)
Duration	Short	Prolonged
Key cells	Neutrophils	Lymphocytes, macrophages, plasma cells
Vascular changes	Prominent	Less prominent
Tissue injury	Mild, often reversible	Prominent, fibrosis
Causes	Infections, trauma	Persistent infections (TB, fungal), autoimmune, foreign material
Outcome	Resolution, abscess, or progression	Scarring/fibrosis

Q12. What are the mediators of inflammation? Classify them.

Cell-derived mediators:

Histamine - first mediator released; from mast cells and basophils; causes vasodilation and increased permeability
Prostaglandins - from arachidonic acid via COX pathway; cause vasodilation, pain, fever
Leukotrienes - from arachidonic acid via lipoxygenase; LTB4 is chemotactic; LTC4/LTD4 increase permeability and cause bronchoconstriction
Cytokines - TNF, IL-1 (from macrophages): systemic effects (fever, acute phase proteins); IL-8: chemotaxis
PAF (Platelet Activating Factor) - bronchoconstriction, chemotaxis
Nitric Oxide (NO) - vasodilation, kills microbes

Plasma-derived mediators (produced in liver, circulate as inactive precursors):

Complement (C3a, C5a) - C5a is most important: chemotaxis, opsonization, MAC formation
Kinin system - bradykinin: pain, vasodilation, increased permeability
Coagulation system - fibrin, thrombin
Robbins & Kumar Basic Pathology

Q13. What is a granuloma? What are its causes?

A: A granuloma is a focal accumulation of activated macrophages (epithelioid cells), often surrounded by lymphocytes, with or without giant cells and central necrosis. It is the hallmark of chronic granulomatous inflammation.

Components:

Epithelioid cells (activated macrophages)
Langhans giant cells (horseshoe-shaped nuclei) or foreign-body giant cells
Peripheral lymphocytes
Central caseous necrosis (in TB)

Causes (mnemonic: "SATCH-B"):

S - Sarcoidosis (non-caseating)
A - Allergic alveolitis
T - Tuberculosis (caseating - most classic)
C - Crohn's disease
H - Histoplasmosis / other fungi
B - Berylliosis, foreign body reaction, leprosy (syphilis)

Q14. What is wound healing? Describe primary vs. secondary intention.

Wound healing involves:

Hemostasis - platelet aggregation, fibrin clot
Inflammation - neutrophils then macrophages clean debris
Proliferation - angiogenesis, fibroblast proliferation, collagen synthesis
Remodeling - collagen cross-linking, scar maturation

Primary intention (1° intention): Clean incised wound with opposed edges. Minimal tissue loss. Narrow scar. E.g., surgical incision.

Secondary intention (2° intention): Wound with large tissue defect. Requires more granulation tissue, greater contraction, larger scar. E.g., abscess cavity, extensive burns.

Factors impairing healing: Infection, malnutrition (vitamin C deficiency - impairs collagen synthesis), diabetes (poor vascularization, immunity), steroids (inhibit inflammation and collagen synthesis), poor blood supply.

UNIT 3: HEMODYNAMICS, THROMBOSIS & SHOCK

Q15. What is thrombosis? What is Virchow's triad?

A: Thrombosis is the formation of a solid mass (thrombus) from blood components within the vasculature in a living individual.

Virchow's Triad (the three predisposing factors):

Endothelial injury - most important in arterial thrombosis; exposes subendothelial collagen → platelet activation. Causes: atherosclerosis, hypertension, vasculitis.
Abnormal blood flow (turbulence/stasis) - prevents dilution of activated clotting factors, reduces laminar flow (keeps platelets away from endothelium). Turbulence causes arterial/cardiac thrombi; stasis causes venous thrombi.
Hypercoagulability - primary (genetic: Factor V Leiden, prothrombin mutation, antithrombin III deficiency) or secondary (acquired: prolonged bed rest, cancer, pregnancy, OCP use).

Q16. What is embolism? What are the types?

A: An embolism is the passage of a detached intravascular mass (embolus) from its site of origin to a distant site.

Types:

Thromboembolism - most common (95%+); DVT → pulmonary embolism (PE) most common
Fat embolism - fractures of long bones, liposuction; fat globules obstruct pulmonary/cerebral vessels
Air embolism - IV injections, surgery; >100 mL can be fatal
Amniotic fluid embolism - obstetric complication; can cause DIC and respiratory failure
Tumor embolism - cancer cells spread via hematogenous route
Paradoxical embolism - embolus crosses from venous to arterial system through a patent foramen ovale

Q17. Define infarction. What factors determine outcome?

A: Infarction is an area of ischemic coagulative necrosis caused by occlusion of the vascular supply (arterial or venous).

Types:

White (anemic) infarct - solid organs with single blood supply (heart, kidney, spleen). Wedge-shaped.
Red (hemorrhagic) infarct - loose tissue (lung, intestine) or organs with dual blood supply; also in venous occlusions.

Factors determining outcome:

Nature of vascular supply (single vs. dual; end artery vs. collateral)
Rate of occlusion (slow → collaterals can develop)
Tissue vulnerability to hypoxia (neurons: 3-5 min; myocardium: 20-30 min; fibroblasts: hours)
Oxygen-carrying capacity of blood (anemia worsens outcome)

Q18. What are the types of shock? What is the mechanism of each?

Type	Mechanism	Examples
Cardiogenic	Pump failure → reduced cardiac output	MI, cardiac tamponade, arrhythmia
Hypovolemic	Loss of blood/fluid volume	Hemorrhage, burns, severe diarrhea
Distributive (Septic)	Systemic vasodilation → maldistribution of flow	Gram-negative sepsis (endotoxin → NO release)
Neurogenic	Loss of vascular tone (autonomic dysfunction)	Spinal cord injury, general anesthesia
Anaphylactic	IgE-mediated mast cell degranulation → massive vasodilation	Bee sting, drug allergy

Stages of shock: (1) Compensated (nonprogressive) → (2) Progressive → (3) Irreversible

UNIT 4: NEOPLASIA

Q19. Define neoplasia. How is a benign tumor different from a malignant tumor?

A: A neoplasm is an abnormal mass of tissue showing uncoordinated growth that exceeds that of normal tissues and persists after the stimulus causing it ceases (Willis's definition). Neoplasia literally means "new growth."

Feature	Benign	Malignant
Differentiation	Well differentiated	Poorly differentiated to anaplastic
Growth rate	Slow	Rapid
Invasion	No invasion	Locally invasive
Metastasis	Never	Yes (hallmark of malignancy)
Border	Encapsulated, well-defined	Irregular, infiltrating
Necrosis/hemorrhage	Rare	Common
Mitoses	Rare, normal	Frequent, atypical
Nuclear features	Normal N:C ratio	High N:C ratio, hyperchromatism, prominent nucleoli

Q20. What are proto-oncogenes, oncogenes, and tumor suppressor genes?

Proto-oncogenes are normal cellular genes that regulate cell growth, differentiation, and death. They become oncogenes when mutated or overexpressed, driving uncontrolled cell proliferation.

Examples:

RAS - most commonly mutated oncogene in human cancers; point mutation → constitutively active GTPase
MYC - transcription factor; amplified in Burkitt lymphoma (t8;14 translocation)
HER2/neu (ERBB2) - amplified in ~25% breast cancers; target of trastuzumab
BCR-ABL - Philadelphia chromosome (t9;22); tyrosine kinase; CML; target of imatinib

Tumor suppressor genes (anti-oncogenes) normally brake cell proliferation. Loss of function (both alleles) allows uncontrolled growth ("two-hit hypothesis" - Knudson):

RB (retinoblastoma gene) - first tumor suppressor described; mutated in retinoblastoma, osteosarcoma
TP53 - "guardian of the genome"; most commonly mutated tumor suppressor; mutated in >50% of all human cancers; Li-Fraumeni syndrome (germline p53 mutation)
APC - mutated in familial adenomatous polyposis (FAP); loss → accumulation of β-catenin
BRCA1/BRCA2 - DNA repair genes; mutations → breast and ovarian cancer

Q21. What are the routes of metastasis? Which tumors spread by each route?

Lymphatic spread - most common for carcinomas (epithelial tumors). Sentinel lymph node is the first draining node. E.g., breast cancer → axillary nodes; colon cancer → mesenteric nodes.
Hematogenous spread - characteristic of sarcomas (connective tissue tumors) but also carcinomas. Travels via veins (portal → liver; systemic veins → lungs; vertebral venous plexus → spine - "Batson plexus").
- Liver - most common site of metastasis overall; GI cancers via portal vein
- Lungs - most common for cancers draining into systemic veins
- Bone - breast, prostate, lung, thyroid, kidney ("BPro-LTK")
- Brain - lung, breast, melanoma, kidney, colon
Seeding of body cavities (transcoelomic) - implantation on peritoneal/pleural surfaces. E.g., ovarian cancer → peritoneal seeding ("Krukenberg tumor" = ovarian metastasis from GI cancer via transcoelomic or hematogenous spread).

Q22. What is the role of p53 in cancer?

A: p53 (encoded by TP53) is a transcription factor and the most important tumor suppressor in humans, mutated in >50% of all cancers.

Functions of normal p53:

DNA damage sensor - activated by DNA strand breaks, hypoxia, oncogene activation
Cell cycle arrest - induces p21 (CDK inhibitor) → G1/S checkpoint arrest → allows DNA repair
Apoptosis - if DNA damage is unrepairable, p53 activates BAX → apoptosis
Senescence - permanent cell cycle arrest
Inhibits angiogenesis - promotes TSP-1 expression

Consequences of p53 loss:

Cells with damaged DNA continue to replicate → accumulation of mutations → cancer
Li-Fraumeni syndrome: germline TP53 mutation → multiple cancers at young age

Q23. What is grading and staging of tumors? Why is staging more important clinically?

Grading refers to the histologic assessment of tumor differentiation (how much it resembles normal tissue):

Grade I: Well differentiated
Grade II: Moderately differentiated
Grade III: Poorly differentiated
Grade IV: Anaplastic/undifferentiated

Staging refers to the extent of tumor spread, assessed clinically and pathologically using the TNM system:

T = Tumor size/local extent (T1-T4)
N = Regional lymph node involvement (N0-N3)
M = Distant metastasis (M0 or M1)

Staging is more important clinically because it directly determines prognosis and treatment (e.g., surgery vs. chemotherapy vs. palliative care). Grading helps select therapy but varies in reliability.

UNIT 5: IMMUNITY & HYPERSENSITIVITY

Q24. Classify hypersensitivity reactions (Gell and Coombs classification).

Type	Name	Mechanism	Mediators	Examples
Type I	Immediate / Anaphylactic	IgE on mast cells → allergen crosslinks IgE → degranulation	Histamine, leukotrienes, prostaglandins	Anaphylaxis, asthma, urticaria, hay fever
Type II	Cytotoxic / Antibody-dependent	IgG/IgM bind cell surface antigens → complement activation or ADCC	Complement, NK cells	Hemolytic disease of newborn, Goodpasture's, autoimmune hemolytic anemia, myasthenia gravis
Type III	Immune complex	Antigen-antibody complexes deposited in tissues → complement → neutrophil recruitment	Complement, neutrophils	SLE, serum sickness, post-streptococcal GN, polyarteritis nodosa
Type IV	Delayed-type (DTH) / Cell-mediated	CD4+ T cells (Th1) or CD8+ CTLs react to antigen 24-72 hrs later	IFN-γ, TNF, cytotoxic T cells	Contact dermatitis, TB skin test (Mantoux), graft rejection, type 1 DM

Q25. What is amyloidosis? How is it classified?

A: Amyloidosis is a pathologic extracellular deposition of insoluble abnormal fibrillar proteins that form beta-pleated sheets. It stains Congo red and shows apple-green birefringence under polarized light.

Classification:

Primary (AL) amyloidosis - light chains from plasma cell dyscrasia (multiple myeloma). Most common type. Affects heart, kidney, tongue, nerves.
Secondary (AA) amyloidosis - serum amyloid A (SAA), an acute phase reactant, in chronic inflammatory diseases (TB, rheumatoid arthritis, IBD, osteomyelitis). Affects kidney (most common organ), liver, spleen.
Hereditary (familial) amyloidosis - mutant transthyretin (TTR). E.g., familial Mediterranean fever → AA type.
Dialysis-related - β2-microglobulin accumulates in long-term dialysis patients (carpal tunnel syndrome).
Localized - e.g., Alzheimer disease (Aβ amyloid in brain plaques), type 2 DM (islet amyloid polypeptide in pancreatic islets).

Key organ effects: Kidney → nephrotic syndrome; Heart → restrictive cardiomyopathy; Spleen → "sago" or "lardaceous" spleen.

UNIT 6: SELECTED ORGAN-SPECIFIC PATHOLOGY

Q26. What are the morphologic features of myocardial infarction (MI) at different time intervals?

Time	Gross	Microscopic
0-4 hrs	Normal	Normal (no changes)
4-12 hrs	Pallor begins	Wavy fibers, coagulation necrosis begins
12-24 hrs	Pallor	Coagulative necrosis, loss of nuclei/striations, neutrophil infiltration begins
1-3 days	Yellow pallor with hyperemic border	Dense neutrophilic infiltrate
3-7 days	Hyperemic border, central yellow-white	Macrophage infiltration, removal of dead cells
1-3 weeks	Fibrovascular granulation tissue	Granulation tissue replaces necrotic muscle
>6 weeks	White fibrous scar	Dense collagen scar

Most common site: Left anterior descending artery (LAD) → anterior wall and septum of LV.

Q27. What are the types of hepatitis and their key features?

Feature	HAV	HBV	HCV	HDV	HEV
Transmission	Fecal-oral	Parenteral, sexual, perinatal	Parenteral (IV drug use #1)	Parenteral (needs HBV)	Fecal-oral
Chronicity	None	5-10%	80%	Yes (with HBV)	None
Cirrhosis	No	Yes	Yes (most common cause in West)	Yes	No
HCC association	No	Yes (HBsAg carrier)	Yes	Yes	No
Vaccine	Yes	Yes	No	HBV vaccine prevents HDV	None widely available

Q28. What is the pathology of tuberculosis? Describe primary vs. secondary TB.

Primary TB:

First exposure, usually in children
Subpleural focus (Ghon focus) + hilar lymph node involvement = Ghon complex
Usually asymptomatic; heals with calcification
Rarely: progressive primary TB or miliary TB in immunocompromised

Secondary (reactivation) TB:

Reactivation of latent primary infection (usually >90% of adult cases)
Usually upper lobe of lung (high O2 tension)
Hallmark: caseating granuloma with central cheese-like necrosis
Complications: cavity formation, bronchiectasis, massive hemoptysis, miliary TB, CNS TB, Pott's disease (vertebral TB), TB lymphadenitis

Key histology: Epithelioid cell granuloma + Langhans giant cells + caseous necrosis + peripheral lymphocytes

Test: Mantoux/PPD (tuberculin skin test) = type IV hypersensitivity; positive >10 mm induration at 48-72 hrs

Q29. What is the pathogenesis of atherosclerosis?

A: The Response to Endothelial Injury hypothesis (Ross):

Endothelial injury (from hypertension, hyperlipidemia, smoking, homocysteine) → endothelial dysfunction
Increased permeability → LDL enters intima → oxidized LDL (ox-LDL)
Monocyte recruitment → monocytes adhere to endothelium (via VCAM-1, ICAM-1) → enter intima → macrophages → engulf ox-LDL → foam cells
Fatty streak - earliest visible lesion (reversible); foam cells + T lymphocytes
Platelet aggregation → smooth muscle migration from media to intima → proliferation + ECM production
Fibrous plaque - necrotic core (foam cells, cellular debris, cholesterol crystals) + fibrous cap (SMC + collagen) → advanced atheroma
Plaque rupture/erosion → thrombosis → acute MI or stroke

Risk factors (major): hyperlipidemia (LDL), hypertension, smoking, diabetes, family history.

Q30. What is carcinoma of the cervix? How does HPV cause it?

Cervical carcinoma is the most common gynecologic malignancy worldwide. Most commonly squamous cell carcinoma (80%); adenocarcinoma (15-20%).

HPV role:

High-risk HPV types (16, 18, 31, 33) - responsible for >95% of cervical cancers
HPV E6 protein → binds and degrades p53
HPV E7 protein → binds and inactivates pRb (retinoblastoma protein)
This releases E2F transcription factor → uncontrolled cell cycle progression

Progression: Normal → CIN I (mild dysplasia) → CIN II (moderate) → CIN III/CIS (severe/carcinoma in situ) → invasive carcinoma

Koilocytes (HPV-infected cells with perinuclear halo and wrinkled nucleus) are the hallmark on Pap smear.

Screening: Pap smear (cervical cytology) + HPV DNA testing Prevention: HPV vaccines (Gardasil/Cervarix) - protect against HPV 16, 18 (and types 6, 11 for genital warts)

UNIT 7: HEMATOLOGY BASICS

Q31. How are anemias classified? Give examples of each.

Morphological classification (by RBC size/color):

Microcytic hypochromic - iron deficiency anemia (most common), thalassemia, sideroblastic anemia, anemia of chronic disease
Macrocytic (normochromic) - megaloblastic (B12/folate deficiency), liver disease, hypothyroidism, drugs (hydroxyurea)
Normocytic normochromic - hemolytic anemia, aplastic anemia, anemia of chronic disease (early), blood loss (acute)

Pathophysiologic classification:

Blood loss (acute vs. chronic)
Increased destruction (hemolytic) - intrinsic (sickle cell, G6PD deficiency, hereditary spherocytosis) or extrinsic (autoimmune, microangiopathic)
Decreased production - iron deficiency, B12/folate deficiency, aplastic anemia, renal failure

Q32. What is sickle cell disease? What is its pathogenesis and complications?

Mutation: Single nucleotide substitution in the beta-globin gene (GAG → GTG), causing glutamate → valine at position 6. This creates HbS.

Pathogenesis: On deoxygenation, HbS polymerizes → RBCs sickle → increased viscosity + occlusion of small vessels + hemolysis.

Triggers of sickling: Hypoxia, acidosis, dehydration, infection, cold.

Complications:

Vaso-occlusive crises - pain crises (bones, chest, abdomen)
Acute chest syndrome - fever + pulmonary infiltrates; most common cause of death in adults
Stroke - especially in children
Splenic sequestration/autosplenectomy - functional asplenia → susceptibility to encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis)
Aplastic crisis - triggered by Parvovirus B19 infection
Avascular necrosis - especially femoral head
Renal papillary necrosis

Diagnosis: Hemoglobin electrophoresis (gold standard) Protection: HbF (fetal Hb) inhibits sickling. Hydroxyurea increases HbF levels.

QUICK RECALL TABLE: KEY STAINS IN PATHOLOGY

Stain	What it identifies
H&E	Routine histology
PAS (Periodic Acid-Schiff)	Glycogen, fungi (Cryptococcus, Histoplasma), basement membranes
Congo red	Amyloid (apple-green birefringence under polarized light)
Ziehl-Neelsen (ZN/AFB)	Acid-fast bacilli (M. tuberculosis, M. leprae)
Gram stain	Bacteria (gram +ve = purple; gram -ve = pink)
Sudan IV / Oil Red O	Lipids/fat (frozen sections)
Prussian Blue (Perl's)	Hemosiderin (iron)
Silver stain (Gomori)	Fungi, Pneumocystis, reticulin fibers
India ink	Cryptococcus capsule
Giemsa	Malaria, Leishmania, chromosomes
Masson's Trichrome	Collagen (blue), muscle (red)

QUICK RECALL: IMPORTANT TUMOR MARKERS

Tumor Marker	Cancer
PSA	Prostate
AFP (alpha-fetoprotein)	Hepatocellular carcinoma, germ cell tumors (yolk sac)
β-hCG	Choriocarcinoma, hydatidiform mole
CEA	Colorectal cancer (also pancreas, lung, breast)
CA-125	Ovarian cancer
CA 19-9	Pancreatic cancer
CA 15-3	Breast cancer
S-100	Melanoma, neural tumors
Calcitonin	Medullary thyroid carcinoma
Chromogranin A	Neuroendocrine tumors

Sources: Robbins & Kumar Basic Pathology (10th ed.) and Robbins, Cotran & Kumar Pathologic Basis of Disease - accessed via the medical textbook library.

This covers all the major topics examined in MBBS pathology. If you want deeper coverage on any specific topic (e.g., renal pathology, CNS tumors, lymphomas, lung pathology, GI diseases), just ask and I'll expand those sections.

Most imp diagram of which should be drawn in exams

Generating all the most important diagrams in parallel now!

Generating Image

Clean medical education diagram titled "Cell Injury & Death Pathways" for MBBS exam. Shows a central healthy cell at top. Three branches: LEFT branch = "Reversible Injury" showing cellular swelling, fatty change, vacuolization with arrows showing return to normal. CENTER branch = "Necrosis" with subtypes listed: Coagulative (MI, kidney), Liquefactive (brain abscess), Caseous (TB), Fat necrosis (pancreatitis), Fibrinoid (vasculitis). RIGHT branch = "Apoptosis" with features: cell shrinkage, chromatin condensation, apoptotic bodies, no inflammation. Bottom row shows comparison table of Necrosis vs Apoptosis with features: cell size, nucleus, membrane, inflammation, causes. White background, clear black text labels, color-coded boxes (blue for reversible, red for necrosis, green for apoptosis), arrows connecting concepts. Medical textbook style.

Generating Image

Medical education diagram titled "Virchow's Triad & Thrombosis" for MBBS exam. Central triangle with three labeled sides: TOP SIDE = "Endothelial Injury" (examples: atherosclerosis, hypertension, smoking), LEFT SIDE = "Abnormal Blood Flow / Stasis / Turbulence" (examples: DVT, atrial fibrillation, varicose veins), RIGHT SIDE = "Hypercoagulability" (primary: Factor V Leiden, prothrombin mutation; secondary: cancer, pregnancy, OCP). Inside triangle: "THROMBUS FORMATION". Below triangle: arrows showing outcomes - "Arterial thrombus → MI, Stroke" and "Venous thrombus → DVT → Pulmonary Embolism". Clean white background, bold labels, color-coded sides (red, blue, purple), medical textbook style suitable for hand-drawing.

Generating Image

Medical education diagram titled "Pathogenesis of Atherosclerosis" for MBBS exam. Step-by-step flowchart with numbered steps going downward: Step 1: Normal artery wall (intima, media, adventitia labeled). Step 2: Endothelial injury (causes listed: hypertension, smoking, hyperlipidemia, diabetes) → endothelial dysfunction. Step 3: LDL enters intima → oxidized LDL (oxLDL). Step 4: Monocytes adhere (VCAM-1, ICAM-1) → become macrophages → engulf oxLDL → FOAM CELLS → FATTY STREAK. Step 5: Platelet aggregation + smooth muscle cell migration from media. Step 6: Fibrous plaque = lipid core + fibrous cap (collagen + SMC). Step 7: Plaque rupture → thrombosis → MI or stroke. Cross-section artery drawings showing progression at each step. White background, clear arrows, red and yellow colors for plaque, medical textbook style.

Generating Image

Medical education diagram titled "Types of Hypersensitivity Reactions (Gell & Coombs)" for MBBS exam. Four horizontal rows, one per type. TYPE I (Immediate/Anaphylactic): allergen → IgE on mast cell → degranulation → histamine, leukotrienes → anaphylaxis, asthma. TYPE II (Cytotoxic): IgG/IgM bind cell surface antigen → complement activation / ADCC → cell death → examples: hemolytic disease of newborn, Goodpasture syndrome, myasthenia gravis. TYPE III (Immune Complex): Ag-Ab complex deposits → complement → neutrophils → tissue damage → SLE, serum sickness, post-strep GN. TYPE IV (Delayed/Cell-mediated): antigen → T cell sensitization → 48-72 hrs → CD4+ Th1 / CD8+ CTL → contact dermatitis, TB skin test, graft rejection. Each type in different color box (yellow, blue, green, orange). White background. Clean medical illustration style, exam-ready.

429 Too Many Requests. {'message': '{\n "error": {\n "code": 429,\n "message": "Resource exhausted. Please try again later. Please refer to https://cloud.google.com/vertex-ai/generative-ai/docs/error-code-429 for more details.",\n "status": "RESOURCE_EXHAUSTED"\n }\n}\n', 'status': 'Too Many Requests'}

We encountered an error while processing your request. Please try again or reach out to us for help.

🔗Contact Support

✉️hi@orris.care

Important questions with answers and with label of pathology

Finding Sources

Reading File

I now have thorough content. Let me compile the full labeled Q&A with topic labels.Here is the complete set of Important Pathology Questions with Answers, each clearly labeled with its topic/chapter tag for quick exam navigation. Based on Robbins & Kumar Basic Pathology and Robbins, Cotran & Kumar Pathologic Basis of Disease.

📚 PATHOLOGY - IMPORTANT Q&A WITH TOPIC LABELS

🏷️ TOPIC: INTRODUCTION TO PATHOLOGY

Q1. What is pathology? Define etiology and pathogenesis.

A: Pathology is the scientific study of the causes of disease and the changes in cells, tissues, and organs associated with disease. It forms the scientific foundation for the practice of medicine.

Etiology = The "WHY" - the origin/cause of a disease, including underlying causes and modifying factors (e.g., genetic susceptibility + environmental triggers)
Pathogenesis = The "HOW" - the step-by-step development of disease from the initial etiologic trigger to the cellular/molecular changes that give rise to structural and functional abnormalities

Exam tip: Etiology = cause; Pathogenesis = mechanism of development.

Source: Robbins & Kumar Basic Pathology

🏷️ TOPIC: CELL INJURY & DEATH

Q2. What are the causes of cell injury? Enumerate.

A: Major causes grouped into categories:

#	Category	Examples
1	Hypoxia and Ischemia	Arterial obstruction (most common), cardiorespiratory failure, anemia
2	Physical agents	Trauma, heat, cold, radiation, electric shock
3	Chemical agents & drugs	Toxins, CCl₄, heavy metals, drugs
4	Infectious agents	Bacteria, viruses, fungi, parasites
5	Immunologic reactions	Autoimmune diseases, hypersensitivity
6	Genetic derangements	Enzyme defects, structural protein abnormalities (e.g., sickle cell)
7	Nutritional imbalances	Protein-calorie malnutrition, vitamin deficiencies, excess nutrition (obesity)

Q3. What are the key biochemical mechanisms of cell injury? Name the four targets.

A: Four key biochemical targets:

CELL INJURY
     │
     ├── 1. MITOCHONDRIA
     │        → ATP depletion → membrane pump failure → swelling
     │        → Irreversible: vacuolation + large amorphous densities
     │
     ├── 2. CELLULAR MEMBRANES
     │        → Damage to plasma, lysosomal, mitochondrial membranes
     │        → Leakage of intracellular enzymes (↑ serum CK, LDH, AST)
     │
     ├── 3. NUCLEUS (DNA)
     │        → Strand breaks from free radicals / toxins
     │        → If irreparable → apoptosis
     │
     └── 4. ENDOPLASMIC RETICULUM (ER)
              → Misfolded protein accumulation → Unfolded Protein Response (UPR)
              → Severe ER stress → apoptosis

Final common pathway of irreversible injury: Massive mitochondrial damage → lysosomal membrane rupture → enzymatic digestion → NECROSIS.

Q4. Compare Reversible vs. Irreversible Cell Injury.

Feature	Reversible	Irreversible
Cause	Mild/brief injury	Severe/prolonged injury
Mitochondria	Swelling, loss of phospholipids	Vacuolization, large amorphous densities
Plasma membrane	Blebbing, blunting of microvilli	Rupture
Nucleus	Chromatin clumping	Pyknosis → karyorrhexis → karyolysis
Lysosomes	Intact	Ruptured
Outcome	Restored to normal	Necrosis or apoptosis

Morphology of reversible injury (H&E):

Cellular swelling (most common, earliest sign)
Fatty change (steatosis)
Cytoplasmic vacuolization
Increased eosinophilia of cytoplasm

Q5. Differentiate Necrosis from Apoptosis. (Very Important - asked in every exam)

Feature	NECROSIS	APOPTOSIS
Definition	Accidental, uncontrolled cell death	Programmed, regulated cell death
Stimulus	Ischemia, toxins, severe injury (pathologic)	Physiologic or pathologic
Cell size	Enlarged (swelling)	Reduced (shrinkage)
Nucleus	Pyknosis → karyorrhexis → karyolysis	Fragmentation into nucleosome-sized pieces
Plasma membrane	Disrupted, destroyed	Intact with altered lipid orientation (blebbing)
Cell contents	Leaked into extracellular space	Packaged into apoptotic bodies
Inflammation	PRESENT - major	ABSENT
Phagocytosis	By neutrophils & macrophages	By adjacent cells & macrophages
Energy (ATP)	Not required	Required (active process)
Examples	MI, ischemic stroke, TB, abscess	Embryogenesis, thymus T-cell deletion, viral hepatitis (councilman bodies)

Key differentiator for exam: Necrosis = inflammation present; Apoptosis = no inflammation.

Q6. What are the morphologic patterns of necrosis? (Most asked)

Pattern	Mechanism	Appearance	Classic Example
Coagulative	Protein denaturation preserves cell outlines (ghost outline)	Pale, firm	MI (heart), renal infarct, splenic infarct
Liquefactive	Enzymatic digestion liquefies tissue	Liquid/pus-filled cavity	Brain infarct, abscess
Caseous	Cheese-like; structureless, amorphous eosinophilic material	Soft, white, cheese-like	Tuberculosis (classic)
Fat necrosis	Lipase digestion of adipose tissue; saponification	Chalky-white deposits (calcium soaps)	Acute pancreatitis, breast trauma
Fibrinoid	Deposition of fibrin-like material in vessel walls	Pink (eosinophilic) smudge in vessel wall	Vasculitis, malignant hypertension
Gangrenous	Coagulative + liquefactive	Dry (coagulative) or Wet (+ bacteria)	Diabetic foot, bowel infarction

Exam mnemonic for patterns: "Can Lick Cats For Fun Generally" Coagulative, Liquefactive, Caseous, fat, Fibrinoid, Gangrenous

🏷️ TOPIC: CELLULAR ADAPTATIONS

Q7. Define and classify cellular adaptations to stress. Give examples.

CELLULAR ADAPTATIONS TO STRESS
         │
    ┌────┴─────────────────────────────────────────────────┐
    ↓           ↓              ↓              ↓             ↓
HYPERTROPHY  HYPERPLASIA   ATROPHY      METAPLASIA    DYSPLASIA
(↑ cell size)(↑ cell no.)  (↓ cell size) (cell type    (disordered
                                          change)        growth)

Adaptation	Definition	Stimulus	Example
Hypertrophy	↑ cell size (no. unchanged)	Increased workload / hormones	Cardiac hypertrophy in HTN; skeletal muscle hypertrophy in bodybuilders
Hyperplasia	↑ cell number	Hormonal stimulation / growth factors	Endometrial hyperplasia (↑ estrogen); benign prostatic hyperplasia
Atrophy	↓ cell size + number	↓ nutrients, disuse, denervation, ↓ blood supply	Muscle wasting; brain atrophy in dementia
Metaplasia	One adult cell type → another (both differentiated)	Chronic irritation	Columnar → Squamous in bronchus (smokers); Squamous → Columnar in lower esophagus (Barrett's)
Dysplasia	Disordered growth - size, shape, organization abnormal	Chronic irritation / pre-malignancy	Cervical dysplasia (CIN 1-3)

Key exam point: Metaplasia is reversible; dysplasia is pre-malignant. Barrett's esophagus = intestinal metaplasia of lower esophagus (squamous → columnar with goblet cells) - predisposes to adenocarcinoma.

🏷️ TOPIC: INTRACELLULAR ACCUMULATIONS & CALCIFICATION

Q8. What are the types of pathologic calcification? How do they differ?

Feature	Dystrophic	Metastatic
Location	Dead/necrotic tissue	Normal/viable tissue
Serum Ca²⁺	NORMAL	ELEVATED (hypercalcemia)
Mechanism	Cell injury → membrane damage → local Ca²⁺ influx	Hypercalcemia → Ca²⁺ deposits in tissues
Causes	TB (caseous necrosis), atherosclerosis, dead parasites, old thrombi	Hyperparathyroidism, extensive bone destruction (metastases), Vit D toxicity, sarcoidosis, milk-alkali syndrome
Sites	At sites of necrosis	Kidneys, lungs, blood vessels, stomach (interstitial)

Q9. Name important intracellular pigment accumulations.

Pigment	Nature	Color	Disease
Lipofuscin	"Wear & tear" pigment; peroxidized lipid	Yellow-brown	Old age, atrophy; accumulates in heart & liver
Melanin	Endogenous; from tyrosine	Brown-black	Melanocytes; melanoma
Hemosiderin	Iron storage; derived from ferritin	Golden-yellow	Hemolysis, hemochromatosis - Prussian blue stain positive
Bilirubin	Hemoglobin breakdown	Yellow-green	Jaundice (hemolytic, obstructive, hepatocellular)
Carbon (anthracosis)	Exogenous	Black	Miners, smokers; lungs + hilar nodes

🏷️ TOPIC: INFLAMMATION

Q10. What is acute inflammation? What are its three main components?

A: Acute inflammation is the rapid, short-duration response of vascularized tissue to infection or injury. It delivers leukocytes and plasma proteins to the site of injury.

Three main components:

Vascular dilation (vasodilation) - redness + warmth (mediated by histamine)
Increased vascular permeability - edema/exudate formation (mediated by histamine, bradykinin, leukotrienes)
Leukocyte emigration - neutrophils first (24 hrs), then monocytes/macrophages (48-72 hrs)

Vascular changes step by step:

Injury
  ↓
Transient vasoconstriction (seconds)
  ↓
Vasodilation → ↑ Blood flow → Redness + Warmth
  ↓
↑ Vascular permeability → Protein-rich exudate leaks → Swelling
  ↓
Stasis of blood → Margination of leukocytes
  ↓
Leukocyte rolling → Adhesion → Transmigration (diapedesis) → Chemotaxis

Q11. What is the difference between exudate and transudate?

Feature	Exudate	Transudate
Protein content	HIGH (>3 g/dL)	LOW (<3 g/dL)
Specific gravity	>1.020	<1.015
Cells	Many (neutrophils, etc.)	Few
Cause	Inflammation (↑ permeability)	Hydrostatic/osmotic imbalance (heart failure, cirrhosis, nephrotic syndrome)
LDH	High	Low
Appearance	Turbid, cloudy	Clear

Q12. Classify and describe the mediators of inflammation.

CELL-DERIVED mediators:

Mediator	Source	Actions
Histamine	Mast cells, basophils, platelets	Vasodilation, ↑ permeability (earliest mediator)
Serotonin	Platelets	Vasoconstriction, ↑ permeability
Prostaglandins (PGs)	Arachidonic acid via COX	Vasodilation (PGI₂, PGE₂), pain, fever
Leukotrienes	Arachidonic acid via LOX	LTB₄: chemotaxis; LTC₄/LTD₄: ↑ permeability, bronchoconstriction
PAF	Leukocytes, endothelium	Platelet activation, chemotaxis, bronchoconstriction
Cytokines	Macrophages, lymphocytes	TNF + IL-1: fever, acute phase proteins; IL-8: neutrophil chemotaxis
Nitric oxide (NO)	Endothelium, macrophages	Vasodilation, kills microbes
ROS	Leukocytes	Kill bacteria, tissue damage

PLASMA-DERIVED mediators (made in liver, circulate as inactive precursors):

Mediator	Functions
Complement (C3a, C5a)	C5a: chemotaxis + opsonization; C3a: anaphylatoxin; MAC (C5b-9): kills microbes
Bradykinin (kinin system)	Vasodilation, ↑ permeability, PAIN
Coagulation factors	Thrombin, fibrin; reinforce inflammatory reaction

Most important chemotactic agent: C5a, LTB₄, IL-8, bacterial products (f-Met-Leu-Phe)

Q13. What are the outcomes of acute inflammation?

ACUTE INFLAMMATION
        │
   ┌────┴────────────────────┬──────────────────┬──────────────┐
   ↓                         ↓                  ↓              ↓
RESOLUTION            SCARRING/FIBROSIS    ABSCESS         CHRONIC
(complete             (if tissue           FORMATION       INFLAMMATION
restoration)          destroyed)          (pus-filled
                                          cavity)

Resolution - complete restoration if minimal tissue destruction (e.g., lobar pneumonia)
Abscess formation - pus-filled cavity walled off by fibrous tissue
Fibrosis/Scarring - extensive tissue destruction → replaced by connective tissue
Chronic inflammation - if stimulus persists (e.g., TB, autoimmune)

Q14. What is chronic inflammation? What are its features?

A: Chronic inflammation is a prolonged (weeks-months) inflammatory response characterized by simultaneous active inflammation, tissue destruction, and attempts at repair (fibrosis).

Key features:

Infiltration by mononuclear cells (lymphocytes, macrophages, plasma cells) - NOT neutrophils
Tissue destruction by activated macrophages
Angiogenesis and fibrosis
Macrophages are the central cell type - activated by IFN-γ from T cells

Causes:

Persistent infections (TB, fungal, viral, helminths)
Autoimmune diseases (rheumatoid arthritis, SLE)
Prolonged exposure to toxic substances (silica → silicosis)
Some foreign bodies

Granulomatous inflammation = specialized form of chronic inflammation with granulomas (epithelioid macrophage clusters)

Q15. What is a granuloma? Classify causes. (Very frequently asked)

A: A granuloma is a focal aggregate of activated macrophages (epithelioid cells) ± giant cells, surrounded by lymphocytes, with or without central necrosis.

Structure of granuloma:

         Peripheral lymphocytes
              ↓       ↓
    ┌─────────────────────────┐
    │  Epithelioid cells      │
    │  (activated macrophages)│  ← center
    │   ± Caseous necrosis    │
    └─────────────────────────┘
          Giant cells (Langhans type - horseshoe nuclei)
          or Foreign-body type (random nuclei)

Type	Necrosis	Causes
Caseating granuloma	YES (caseous)	Tuberculosis (classic), Histoplasmosis, Coccidioidomycosis
Non-caseating granuloma	NO	Sarcoidosis (most classic), Crohn's disease, Berylliosis, foreign body reaction, leprosy (tuberculoid type)

Exam point: TB = caseating; Sarcoidosis = non-caseating

🏷️ TOPIC: TISSUE REPAIR & WOUND HEALING

Q16. Describe wound healing by primary and secondary intention.

Feature	Primary Intention (1°)	Secondary Intention (2°)
Wound	Clean, incised, edges approximated	Open wound with large defect
Tissue loss	Minimal	Substantial
Inflammation	Minimal	Extensive
Granulation tissue	Little	Abundant
Contraction	Minimal	Significant (myofibroblasts)
Scar	Narrow, thin	Wide, prominent
Example	Surgical incision	Abscess, ulcer, large burn

Phases of wound healing:

Hemostasis (immediate) - platelet plug + fibrin clot
Inflammation (days 1-3) - neutrophils → macrophages clean debris
Proliferation (days 3-10) - angiogenesis + fibroblasts + collagen synthesis → granulation tissue
Remodeling (weeks-months) - collagen cross-linking + scar contraction → mature scar

Factors impairing healing:

Local: Infection, poor blood supply, foreign body, necrotic tissue
Systemic: Malnutrition (Vitamin C deficiency impairs collagen synthesis), diabetes mellitus, corticosteroids (inhibit inflammation + collagen synthesis), immunosuppression

🏷️ TOPIC: HEMODYNAMIC DISORDERS

Q17. What is Virchow's Triad? Explain each component.

A: Virchow's Triad = three factors predisposing to thrombosis:

           VIRCHOW'S TRIAD
          ┌───────────────────┐
          │   THROMBOSIS      │
          └────────┬──────────┘
         ┌─────────┼──────────┐
         ↓         ↓          ↓
   Endothelial   Stasis /   Hypercoag-
     Injury     Turbulence   ulability

Component	Significance	Examples
1. Endothelial Injury	Most important for arterial thrombosis; exposes subendothelial collagen → platelet activation	Atherosclerosis, hypertension, vasculitis, trauma
2. Abnormal Blood Flow (Stasis / Turbulence)	Prevents dilution of clotting factors; allows platelet-endothelium contact. Stasis → venous; turbulence → arterial thrombi	DVT (stasis), atrial fibrillation (stasis), aneurysm (turbulence)
3. Hypercoagulability	Primary (inherited): Factor V Leiden (most common), prothrombin gene mutation, antithrombin III deficiency. Secondary (acquired): cancer, pregnancy, OCP, prolonged bed rest, DIC	Recurrent DVT/PE

Q18. What is the difference between arterial and venous thrombi?

Feature	Arterial Thrombus	Venous Thrombus
Main cause	Endothelial injury	Stasis (Virchow)
Composition	Platelet-rich ("white thrombus")	RBC-rich ("red thrombus" / "lines of Zahn")
Occlusion	Usually complete	Usually partial
Common sites	Coronary arteries, carotid, cerebral	Deep veins of legs (DVT), pelvic veins
Consequence	MI, stroke	Pulmonary embolism

Q19. What are the fates/outcomes of a thrombus?

THROMBUS
    │
    ├──► RESOLUTION (fibrinolysis) - thrombus dissolved by plasmin → best outcome
    ├──► PROPAGATION - grows larger
    ├──► EMBOLIZATION - detaches → travels to distant sites → PE, stroke
    ├──► ORGANIZATION & RECANALIZATION - fibroblasts/endothelium invade → new small channels form
    └──► CALCIFICATION - phlebolith (in veins)

Q20. What are the types of embolism?

Type	Description	Clinical
Thromboembolism	Most common (95%+); DVT → PE	Sudden dyspnea, chest pain, hemoptysis
Fat embolism	Long bone fractures, liposuction	Triad: dyspnea + neurologic symptoms + petechial rash (Fat Embolism Syndrome)
Air embolism	IV lines, surgery, decompression	>100 mL air fatal; "mill-wheel" cardiac murmur; "bends" in divers
Amniotic fluid embolism	Obstetric complication	Sudden dyspnea + DIC
Paradoxical embolism	Venous embolus crosses to arterial through patent foramen ovale	Systemic infarction from venous source
Tumor embolism	Cancer cells in bloodstream	Hematogenous metastasis

Q21. What is infarction? Compare red and white infarcts.

A: Infarction = ischemic coagulative necrosis from vascular occlusion.

Feature	White (Anemic) Infarct	Red (Hemorrhagic) Infarct
Tissue	Solid organs with single blood supply	Loose tissue OR dual blood supply OR venous occlusion
Appearance	Pale, white-yellow, wedge-shaped	Red (blood-soaked)
Examples	Heart (MI), Kidney, Spleen	Lung, intestine, testis (torsion), ovary, brain (with reperfusion)
Mechanism	Blood cannot re-enter compressed parenchyma	Blood re-enters from collaterals or dual supply

🏷️ TOPIC: NEOPLASIA

Q22. Define neoplasm. Compare benign vs. malignant tumors.

A: Neoplasm (Willis's definition): An abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of the normal tissues, and persists in the same excessive manner after cessation of the stimuli which evoked the change.

Feature	BENIGN	MALIGNANT
Differentiation	Well differentiated	Poorly differentiated → anaplastic
Growth rate	Slow	Rapid
Mitoses	Rare, normal	Frequent, atypical
Invasion	No	Yes (local)
Metastasis	NEVER	Hallmark of malignancy
Capsule	Usually encapsulated	No capsule, infiltrating border
Necrosis/hemorrhage	Rare	Common
Nucleus	Normal N:C ratio	High N:C ratio, hyperchromatism, prominent nucleoli
Recurrence after surgery	Rare	Common

Q23. What is the nomenclature (naming) of tumors?

Cell of origin	Benign	Malignant
Epithelial - squamous	Squamous papilloma	Squamous cell carcinoma
Epithelial - glandular	Adenoma	Adenocarcinoma
Epithelial - transitional	Transitional cell papilloma	Transitional cell carcinoma (urothelial)
Fibroblast	Fibroma	Fibrosarcoma
Smooth muscle	Leiomyoma	Leiomyosarcoma
Skeletal muscle	Rhabdomyoma	Rhabdomyosarcoma
Bone	Osteoma	Osteosarcoma
Cartilage	Chondroma	Chondrosarcoma
Fat	Lipoma	Liposarcoma
Blood vessels	Hemangioma	Angiosarcoma
Lymphocytes	-	Lymphoma
Melanocytes	Nevus (mole)	Melanoma
Plasma cells	-	Multiple myeloma

Exceptions (benign-sounding but malignant): Melanoma, hepatoma, seminoma, lymphoma, mesothelioma, glioma - all MALIGNANT.

Q24. What are proto-oncogenes and tumor suppressor genes? Give examples.

Proto-oncogenes = Normal genes promoting cell growth. When mutated → Oncogenes (dominant, one mutant allele sufficient).

Oncogene	Mechanism	Cancer
RAS	Point mutation → constitutively active; most common oncogene mutation in human cancer	Pancreatic, colorectal, lung cancers
MYC	Transcription factor; amplification	Burkitt lymphoma (t8;14 translocation)
HER2/neu	↑ Growth factor receptor; amplification	Breast cancer (~25%); target of trastuzumab
BCR-ABL	t(9;22) Philadelphia chromosome; tyrosine kinase	CML; target of imatinib
EGFR	Tyrosine kinase receptor; overexpression/mutation	Lung adenocarcinoma; erlotinib target

Tumor Suppressor Genes = Normal brakes on cell growth. Both alleles must be lost for cancer - "Two-Hit Hypothesis" (Knudson). Loss of function (recessive).

Gene	Function	Cancer
RB (retinoblastoma gene)	Cell cycle G1→S checkpoint control	Retinoblastoma, osteosarcoma
TP53	"Guardian of the genome"; DNA damage → cell cycle arrest → repair or apoptosis	>50% of ALL human cancers; Li-Fraumeni syndrome
APC	Regulates β-catenin (WNT pathway)	Familial adenomatous polyposis (FAP); colorectal cancer
BRCA1/2	DNA double-strand break repair	Breast cancer, ovarian cancer
CDKN2A (p16)	CDK4 inhibitor	Melanoma, pancreatic cancer
VHL	HIF regulation; prevents angiogenesis	Renal cell carcinoma

Q25. What is the role of p53 in cancer prevention?

A: p53 (encoded by TP53) is the most important tumor suppressor - "Guardian of the genome." It is mutated in >50% of all human cancers.

Normal p53 pathway:

DNA damage / hypoxia / oncogene activation
              ↓
          p53 activated
         (phosphorylated)
              ↓
    ┌─────────┴──────────────┐
    ↓                        ↓
Cell cycle arrest         Activate DNA
(induces p21 →          repair genes
G1/S block)                 ↓
    ↓                  DNA repaired?
(Time for repair)          ↓
    ↑ YES              NO ↓
    └──── Resume ──   p53 → BAX → Apoptosis
           cycle         OR → Senescence

Consequences of p53 LOSS:

DNA damaged cells bypass G1 checkpoint
Mutations accumulate
→ Malignant transformation
Li-Fraumeni syndrome = germline TP53 mutation → multiple cancers (sarcomas, breast, brain, leukemia) at young age

Source: Robbins & Kumar Basic Pathology, Block 3

Q26. Classify and describe the routes of metastasis.

A: Metastasis = spread of cancer to anatomically discontinuous site. Hallmark of malignancy.

Routes:

1. Lymphatic spread (most common for carcinomas)

Follows lymphatics to regional nodes → sentinel node → distant nodes
Examples: Breast → axillary nodes; colon → mesenteric nodes; gastric cancer → left supraclavicular (Virchow's node = Troisier's sign)

2. Hematogenous spread (most common for sarcomas; also carcinomas)

Via veins (thinner walls than arteries)
Portal vein → Liver (most common metastatic organ in GI cancers)
Systemic veins → Lungs
Vertebral plexus (Batson) → Spine
Common targets: Liver, Lung, Bone, Brain, Adrenal glands

3. Seeding of body cavities (Transcoelomic spread)

Implantation on peritoneal/pleural/pericardial surfaces
Classic: Ovarian carcinoma → peritoneal seeding
Krukenberg tumor = bilateral ovarian metastases (usually from gastric adenocarcinoma; signet ring cells)

Q27. What is grading vs. staging of tumors?

	GRADING	STAGING
Definition	Histologic degree of differentiation	Extent of tumor spread
Assessment	Microscopic (pathologist)	Clinical + radiological + pathological
System	Grade I (well diff.) to Grade IV (anaplastic)	TNM: T=Tumor, N=Nodes, M=Metastasis
Clinical importance	Guides therapy selection	More important - determines prognosis + treatment
Examples	Gleason score (prostate), Fuhrman grade (renal)	Stage I-IV in most cancers

Staging > Grading for prognosis because it reflects how far the cancer has spread.

🏷️ TOPIC: IMMUNOPATHOLOGY & HYPERSENSITIVITY

Q28. Classify hypersensitivity reactions with mechanism and examples. (Most important)

Type	Name	Antibody/Cell	Mechanism	Examples
Type I	Immediate / Anaphylactic	IgE	IgE on mast cells → allergen crosslinks → degranulation → histamine, leukotrienes	Anaphylaxis, bronchial asthma, urticaria, hay fever, food allergy
Type II	Antibody-mediated Cytotoxic	IgG/IgM	Antibody binds cell surface Ag → complement-mediated lysis or ADCC	Hemolytic disease of newborn (Rh incompatibility), autoimmune hemolytic anemia, Goodpasture's disease, Graves' disease, myasthenia gravis
Type III	Immune Complex	IgG	Ag-Ab complexes deposit in tissues → complement activation → neutrophil recruitment → tissue damage	SLE, serum sickness, post-streptococcal GN, polyarteritis nodosa
Type IV	Delayed-type (DTH) / Cell-mediated	CD4+ T cells / CD8+ CTLs	T cell sensitization (24-72 hrs) → cytokine release (IFN-γ) → tissue damage	Tuberculin (Mantoux) skin test, contact dermatitis, graft rejection, type 1 DM

Mnemonics: Types I-III = antibody-mediated; Type IV = T cell-mediated (no antibody) Time: Type I = immediate (mins); Type IV = delayed (48-72 hrs)

🏷️ TOPIC: AMYLOIDOSIS

Q29. What is amyloidosis? Classify with examples.

A: Amyloidosis = extracellular deposition of insoluble abnormal fibrillar proteins forming beta-pleated sheets.

Stain: Congo red → apple-green birefringence under polarized light (pathognomonic)

Type	Protein	Precursor	Causes	Organs affected
Primary (AL)	AL (amyloid light chain)	Immunoglobulin light chains	Multiple myeloma, MGUS	Heart, kidney, GI, tongue, nerves
Secondary (AA)	AA (amyloid-associated)	Serum amyloid A (SAA) acute phase protein	Chronic inflammation: TB, RA, IBD, osteomyelitis	Kidney (most common), liver, spleen
Familial/Hereditary	ATTR (transthyretin)	Mutant transthyretin	Familial Mediterranean fever (AA type); familial amyloid polyneuropathy	Peripheral nerves, heart
Dialysis-associated	Aβ₂M	β₂-microglobulin	Long-term hemodialysis	Carpal tunnel, joints
Alzheimer disease	Aβ	Amyloid precursor protein (APP)	Aging, Down syndrome	Brain (senile plaques)
Type 2 DM	AIAPP	Islet amyloid polypeptide	Type 2 diabetes	Pancreatic islets

Organ effects:

Kidney → nephrotic syndrome (most common functional abnormality)
Heart → restrictive cardiomyopathy ("nutmeg" or "rubber" consistency)
Spleen → "sago spleen" (AL-periarteriolar) or "lardaceous spleen" (AA-sinusoidal)

🏷️ QUICK REFERENCE TABLES

Important Special Stains

Stain	Identifies	Color
H&E	Routine (nuclei blue, cytoplasm pink)	Blue/pink
PAS	Glycogen, fungi, BM	Magenta
Congo Red	Amyloid	Apple-green (polarized)
Ziehl-Neelsen (ZN)	Acid-fast bacilli (TB, leprae)	Red on blue
Prussian Blue (Perl's)	Hemosiderin/iron	Blue
Sudan IV / Oil Red O	Lipid/fat	Orange-red
Silver (Gomori/GMS)	Fungi, Pneumocystis, reticulin	Black
India Ink	Cryptococcus capsule	Halo (negative stain)
Masson's Trichrome	Collagen	Blue
Giemsa	Malaria, Leishmania, chromosomes	Purple/blue

Important Tumor Markers

Marker	Tumor
PSA	Prostate carcinoma
AFP	Hepatocellular carcinoma, Yolk sac tumor
β-hCG	Choriocarcinoma, Hydatidiform mole
CEA	Colorectal cancer (also pancreas, lung, breast)
CA-125	Ovarian carcinoma
CA 19-9	Pancreatic carcinoma
Calcitonin	Medullary thyroid carcinoma
S-100	Melanoma, Neural tumors, Langerhans cell histiocytosis
Chromogranin A	Neuroendocrine tumors, carcinoid
Inhibin	Granulosa cell tumor (ovary)
PLAP	Seminoma

High-Yield One-Liners

Fact	Answer
Earliest morphologic change in cell injury	Cellular swelling
Most common type of necrosis	Coagulative
Hallmark of irreversible injury	Karyorrhexis + mitochondrial amorphous densities
First cell in acute inflammation	Neutrophil (PMN)
Predominant cell in chronic inflammation	Macrophage
Most important chemotactic agent	C5a
Central cell in granuloma	Epithelioid macrophage
Most common oncogene mutation in human cancer	RAS (point mutation)
Most commonly mutated tumor suppressor	TP53 (>50% of all cancers)
Two-hit hypothesis related to	RB (retinoblastoma gene)
Hallmark of malignancy	Metastasis
Most common site of hematogenous metastasis	Liver
Congo red + apple-green birefringence	Amyloid
Caseous necrosis =	TB (most classic)
Non-caseating granuloma =	Sarcoidosis (most classic)
HPV types in cervical cancer	16, 18 (high risk)
Most common tumor marker used in practice	PSA (prostate)

All content sourced from: Robbins & Kumar Basic Pathology (10th ed.) and Robbins, Cotran & Kumar Pathologic Basis of Disease - via the medical textbook library.

Important diagram of pathology exam oriented and histopathology slide with labelling

I'll pull actual histopathology slide images from the Robbins textbooks in the library, then generate exam-oriented labeled diagrams. Let me do both in parallel.

Finding Sources

Reading File

I have image URLs. Let me now fetch the key histopathology images AND search for more across the important topics simultaneously.

Loading Image

Finding Sources

Reading File

Finding Sources

Now let me fetch the TB granuloma, necrosis patterns, and MI infarct images, and also look for apoptosis and amyloid slide images in parallel.

Loading Image

Reading File

Finding Sources

Excellent — I have all the image URLs I need. Let me now fetch the remaining key histology slides in parallel.

Loading Image

Reading File

Now let me get the amyloid Congo red image and atherosclerosis plaque image.

Reading File

Loading Image

Here are all the most important pathology diagrams and histopathology slides with full labelling, directly from Robbins & Kumar Basic Pathology. Each one is exam-oriented with what to look for and what to write in your answer.

🔬 IMPORTANT PATHOLOGY DIAGRAMS & HISTOPATHOLOGY SLIDES

1. 🏷️ TOPIC: CELL DEATH - APOPTOSIS (Diagram from Robbins)

Apoptosis diagram showing healthy cell → cell shrinkage → chromatin condensation → membrane blebs → apoptotic bodies → phagocytosis

📌 Labels to know (from this diagram):

Structure seen	What it means
Reduced cell size	Cell shrinks (opposite of necrosis = swells)
Peripheral condensation of chromatin	Nucleus becomes dark, crescent-shaped at periphery
Membrane blebs	Intact plasma membrane forms bubble-like protrusions
Cellular fragmentation	Cell breaks into fragments (not lysis)
Nuclear fragmentation	Nucleus breaks into pieces
Apoptotic bodies	Membrane-bound packages of cell contents
Phagocyte engulfs apoptotic body	No inflammation - silent death

✍️ Exam write-up: "Apoptosis shows cell shrinkage, chromatin condensation at periphery of nucleus, intact membrane with blebs, formation of apoptotic bodies, and phagocytosis WITHOUT inflammatory reaction. This is the key feature distinguishing it from necrosis."

2. 🏷️ TOPIC: CELL INJURY - Reversible vs. Irreversible (H&E: Kidney tubules)

Three-panel H&E showing A: Normal kidney tubules, B: Reversible ischemic injury with blebs, C: Necrosis with loss of nuclei

📌 Labels to identify in each panel:

Panel	What you see	Diagnosis
A (Normal)	Regular tubular cells, round nuclei, well-defined borders	Normal kidney tubule epithelium
B (Reversible)	Surface blebs on luminal surface, ↑ eosinophilia (pink), occasional cell swelling	Reversible ischemic injury
C (Irreversible/Necrosis)	Loss of nuclei (anucleate cells), fragmented cells, pink "ghost" outlines, leakage of contents	Coagulative necrosis (irreversible)

✍️ Exam answer: "Panel C shows coagulative necrosis - cells are eosinophilic (pink), nuclei are absent (karyolysis/pyknosis/karyorrhexis), cell outlines (ghost cells) are preserved but contents are lost."

3. 🏷️ TOPIC: COAGULATIVE NECROSIS - Kidney Infarct (H&E)

H&E microscopy of kidney infarct showing N = normal tissue, I = infarcted/necrotic area with preserved architecture but lost nuclei

📌 Labels:

N = Normal renal tubules (nuclei visible, structured)
I = Infarcted/necrotic area - tubular outlines preserved but nuclei absent = ghost cells
Also visible: glomerulus on left side (normal)

✍️ Exam write-up: "Coagulative necrosis of kidney: The architecture is preserved (tubular outlines visible) but nuclei are lost. These are 'ghost cells' or 'shadow cells'. An inflammatory infiltrate is present at the border. This pattern is seen in ischemic infarcts of solid organs (heart, kidney, spleen)."

4. 🏷️ TOPIC: FIBRINOID NECROSIS - Vasculitis (H&E)

H&E of artery in polyarteritis nodosa showing fibrinoid necrosis - bright pink smudgy deposits in vessel wall with inflammatory infiltrate

📌 Labels:

Bright pink (eosinophilic) smudgy material in the vessel wall = fibrinoid deposits (immune complexes + plasma proteins)
Vessel lumen (red blood cells visible centrally)
Dense inflammatory infiltrate (dark nuclei) surrounding the vessel wall
Destruction of normal vessel architecture

✍️ Exam write-up: "Fibrinoid necrosis: The vessel wall shows circumferential bright pink, amorphous, fibrin-like deposits (fibrinoid) with destruction of normal architecture and surrounding acute inflammatory cells. Classic in polyarteritis nodosa and malignant hypertension. Seen only on microscopy (no gross appearance)."

5. 🏷️ TOPIC: GRANULOMATOUS INFLAMMATION - Tuberculosis (H&E)

Four-panel TB histology: A=low power tubercle, B=higher power with caseous center and giant cells, C=non-caseating granuloma, D=acid-fast stain showing macrophages packed with mycobacteria

📌 Labels for each panel:

Panel	Features	What to write
A (Low power)	Central pale pink area = caseous necrosis, surrounded by cellular zone	Typical TB tubercle at low power
B (Medium power)	Central caseous necrosis (granular, pink, amorphous), peripheral epithelioid macrophages, Langhans giant cells (round cells with multiple nuclei arranged in horseshoe/peripheral pattern)	Classic caseating granuloma
C (Non-caseating)	Granuloma WITHOUT central necrosis; epithelioid cells + giant cells + lymphocytes	Non-caseating granuloma (Sarcoidosis-like)
D (AFB/Acid-fast stain)	Bright red bacilli inside macrophages on blue background	Immunocompromised TB - macrophages packed with AFB

✍️ Exam write-up: "TB granuloma shows: (1) Central caseous necrosis - amorphous granular eosinophilic material, no cellular outline; (2) Epithelioid cells (activated macrophages) - pale pink cytoplasm, elongated nuclei; (3) Langhans giant cells - multiple nuclei arranged in horseshoe/peripheral pattern; (4) Peripheral rim of lymphocytes. ZN stain shows acid-fast bacilli (red on blue)."

6. 🏷️ TOPIC: ATHEROSCLEROSIS - Gross Lesions (Aorta)

Gross aorta specimens showing A: Mild atherosclerosis with early plaques (arrow), B: Severe atherosclerosis with ulcerated plaques, calcification, and dark hemorrhagic areas

📌 Labels:

Image A	Image B
Aorta opened longitudinally	Aorta with advanced disease
Raised yellowish fibrous plaque (arrow) = early atheroma	Multiple ulcerated plaques
Minimal luminal narrowing	Calcification (brown hard deposits)
Intimal surface relatively smooth elsewhere	Thrombus over ruptured plaque (dark areas)

✍️ Exam write-up: "Atherosclerosis: A shows an early fibrous plaque - raised, yellow-white intimal thickening. B shows advanced disease with ulcerated, calcified plaques, plaque rupture, and superimposed thrombosis. This progression (fatty streak → fibrous plaque → complicated plaque) is the basis for MI and stroke."

Pathogenesis to draw in exam:

Normal vessel
     ↓
Endothelial injury (HTN, smoking, hyperlipidemia)
     ↓
LDL enters intima → oxidized LDL
     ↓
Monocytes adhere (VCAM-1) → Macrophages → engulf oxLDL
     ↓
FOAM CELLS → FATTY STREAK (reversible)
     ↓
Platelet aggregation + SMC migration from media
     ↓
FIBROUS PLAQUE (necrotic core + fibrous cap)
     ↓
Plaque rupture → THROMBOSIS → MI / Stroke

7. 🏷️ TOPIC: FATTY STREAK - Atherosclerosis Microscopy (H&E)

A: Gross aortic fatty streak near branch ostia (yellow); B: Microscopy showing intimal foam cells (arrows = macrophage-derived foam cells)

📌 Labels:

Panel A (Gross): Yellowish linear deposits near ostia of branch vessels = fatty streaks. Earliest visible atherosclerotic lesion.
Panel B (Microscopy): Foam cells in intima (arrows) = macrophages that have engulfed oxidized LDL. Cells appear pale with vacuolated cytoplasm (lipid washed out in processing).

✍️ Exam write-up: "Fatty streak: Earliest lesion in atherosclerosis. Gross: flat yellow intimal deposits near vessel branch points. Micro: Subintimal accumulation of foam cells - macrophages with lipid-filled (vacuolated) cytoplasm. Completely reversible at this stage."

8. 🏷️ TOPIC: AMYLOIDOSIS - Congo Red Staining (Polarized Light)

Congo red stain under polarized light showing apple-green birefringence of amyloid fibrils - the pathognomonic finding for amyloidosis

📌 Labels:

Yellow-green (apple-green) birefringent material = AMYLOID FIBRILS
Deposits in tissue architecture (vessel walls, glomeruli, or interstitium depending on organ)
This is only seen under POLARIZED LIGHT after Congo red staining
Under ordinary light: pink/red deposits; under polarized: apple-green

✍️ Exam write-up: "Amyloid stains with Congo red and shows apple-green birefringence under polarized light - pathognomonic feature. The fibrils form beta-pleated sheets. This yellow-green color is the single most important feature to identify amyloid in any histopathology slide. H&E shows amorphous, eosinophilic, hyaline extracellular deposits."

🗂️ SUMMARY: What to Draw & What to Write - Exam Cheat Sheet

Slide/Diagram	Topic	Key Labels	Key Exam Line
Apoptosis diagram	Cell death	Cell shrinkage, chromatin condensation, apoptotic bodies, phagocyte	"No inflammation" - distinguishes from necrosis
Kidney tubules H&E (3 panels)	Reversible vs. irreversible injury	Normal → blebs → ghost cells	Ghost cells + no nuclei = coagulative necrosis
Coagulative necrosis kidney	Infarction	N = normal, I = infarcted; ghost tubules	Preserved architecture, lost nuclei
Fibrinoid necrosis artery	Vasculitis / immune complex	Bright pink amorphous vessel wall, inflammatory infiltrate	Only seen microscopically
TB granuloma H&E	Chronic granulomatous inflammation	Caseous necrosis, epithelioid cells, Langhans giant cells, lymphocytes	ZN stain for AFB
Aortic plaques (gross)	Atherosclerosis	Fatty streak → fibrous plaque → ulcerated plaque	Plaque rupture → thrombosis → MI
Fatty streak (micro)	Atherosclerosis (earliest)	Foam cells in intima	Vacuolated macrophages = foam cells
Congo red polarized	Amyloidosis	Apple-green birefringence	Pathognomonic for amyloid

All histopathology images are from Robbins & Kumar Basic Pathology (10th ed.), accessed via the medical textbook library.

Sustemi Systemic pathology important questions with answers.

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive content from Robbins across all major systemic pathology topics. Let me compile the full Q&A.Here is the complete Systemic Pathology Important Questions & Answers for MBBS — organized organ-system wise with topic labels, sourced from Robbins & Kumar Basic Pathology and Robbins Pathologic Basis of Disease.

🫀🫁🧠 SYSTEMIC PATHOLOGY — IMPORTANT Q&A (MBBS)

🏷️ SYSTEM 1: CARDIOVASCULAR PATHOLOGY (CVS)

Q1. What is heart failure (congestive cardiac failure - CCF)? Describe left-sided and right-sided heart failure.

A: Heart failure (CHF) is the common end point of many cardiac diseases where the heart cannot generate sufficient output to meet the metabolic demands of the body — or can do so only at higher-than-normal filling pressures.

Causes of Left-sided CHF: Ischemic heart disease (most common), systemic hypertension, mitral/aortic valve disease, cardiomyopathy.

Pathophysiology:

↓ Cardiac output (forward failure)
         +
↑ Pulmonary venous back-pressure (backward failure)
         ↓
↑ Pulmonary capillary pressure → Pulmonary edema

Compensatory mechanisms:

Frank-Starling mechanism — ventricular dilation → increased preload → increased contractility (compensated failure)
Neurohumoral activation — norepinephrine (↑ HR, ↑ contractility), RAAS activation (salt/water retention, vasoconstriction), ANP release (counterbalances RAAS)
Myocardial hypertrophy — new sarcomeres added; concentric (pressure overload — HTN) vs. eccentric (volume overload — regurgitation)

Left-sided CHF — Effects:

Organ	Change
Lungs	Pulmonary edema, "cardiac asthma," pink frothy sputum, brown induration (hemosiderin-laden macrophages = "heart failure cells")
Kidneys	↓ perfusion → prerenal azotemia; RAAS activation → fluid retention
Brain	Hypoxic encephalopathy

Right-sided CHF — Causes: Usually consequence of left-sided failure; also cor pulmonale (COPD → pulmonary HTN)

Right-sided CHF — Effects:

Organ	Change
Liver	"Nutmeg liver" (centrilobular congestion → cardiac cirrhosis)
Spleen	Congestive splenomegaly
Legs	Pitting edema (dependent)
Body cavities	Ascites, pleural effusion, anasarca

Source: Robbins & Kumar Basic Pathology

Q2. What is ischemic heart disease (IHD)? What are its forms?

A: IHD is a group of conditions caused by imbalance between myocardial oxygen supply and demand, almost always due to atherosclerosis of the coronary arteries.

Forms of IHD:

Angina pectoris — chest pain on exertion; no necrosis
- Stable angina (fixed plaque, predictable)
- Unstable angina (plaque disruption, unpredictable — "acute coronary syndrome")
- Prinzmetal/variant angina (coronary vasospasm)
Acute Myocardial Infarction (MI) — ischemic necrosis of myocardium
Chronic IHD / Ischemic cardiomyopathy — progressive heart failure from cumulative ischemia
Sudden cardiac death — usually due to lethal arrhythmia from ischemia

Q3. Describe the pathology of acute myocardial infarction (MI). What are the morphological changes at different time intervals?

Cause: >90% due to acute plaque rupture/erosion + superimposed coronary thrombosis → complete occlusion.

Most common artery involved:

LAD (left anterior descending) → anterior wall + septum (40-50%)
RCA (right coronary artery) → posterior wall + right ventricle
LCX (left circumflex) → lateral wall

Morphological changes over time:

Time	Gross	Microscopy
0-4 hours	Normal (no change)	Normal / wavy fiber change
4-12 hours	Pallor begins	Early coagulative necrosis, wavy fibers, ↑ eosinophilia
12-24 hours	Pallor + yellow-tan	Coagulative necrosis - loss of nuclei, striations; neutrophil infiltration begins
1-3 days	Yellowing with hyperemic (red) border	Dense neutrophilic infiltrate, nuclear pyknosis → karyolysis
3-7 days	Soft yellow-white center, red border	Macrophage infiltration begins; dead cells cleared
1-3 weeks	Vascular granulation tissue (pink-red, soft)	Granulation tissue - angiogenesis + fibroblasts + collagen
>6 weeks	White fibrous scar	Dense collagen scar (permanent)

Complications of MI:

Arrhythmia — most common cause of death in 1st hour (ventricular fibrillation)
Cardiogenic shock — pump failure
Mural thrombus → systemic embolism
Cardiac rupture — days 3-7 (at softest point of healing)
Ventricular aneurysm — paradoxical bulge on ECG
Pericarditis — early (fibrinous, 1-3 days), late (Dressler syndrome — autoimmune, weeks later)
Reinfarction
Papillary muscle rupture → acute mitral regurgitation

Source: Robbins & Kumar Basic Pathology

Q4. What is the pathogenesis of atherosclerosis? Describe the "Response to Endothelial Injury" hypothesis.

Step-by-step pathogenesis:

RISK FACTORS: Hypertension, hyperlipidemia (LDL), smoking, diabetes
                          ↓
          1. ENDOTHELIAL INJURY / DYSFUNCTION
                          ↓
          2. LDL enters intima → oxidized LDL (ox-LDL)
                          ↓
          3. Monocytes adhere to endothelium (VCAM-1, ICAM-1)
             → Enter intima → Macrophages
             → Engulf ox-LDL via scavenger receptors
             → FOAM CELLS
                          ↓
          4. FATTY STREAK (reversible earliest lesion)
                          ↓
          5. SMC migration from media → intima
             SMC proliferation + ECM (collagen) production
             Platelet activation → growth factors (PDGF, FGF)
                          ↓
          6. FIBROUS PLAQUE = Lipid core + Fibrous cap
                          ↓
          7. VULNERABLE PLAQUE: thin fibrous cap,
             large lipid core, many inflammatory cells
                          ↓
          8. PLAQUE RUPTURE → Thrombosis
                          ↓
          Acute MI / Stroke / Peripheral vascular disease

Vulnerable plaque features: thin fibrous cap, large lipid core, abundant foam cells, few SMCs, many inflammatory cells. Stable plaque = thick fibrous cap, dense collagen, fewer inflammatory cells.

Q5. What are the types of cardiomyopathy?

Type	Chamber	Mechanism	Causes	Key Features
Dilated (DCM)	All chambers dilated; ↓ EF	Systolic dysfunction	Alcohol, viral myocarditis, idiopathic, genetic, pregnancy (PPCM)	"Flabby" heart; mural thrombi; S3 gallop
Hypertrophic (HCM)	Massive ventricular hypertrophy (especially septum)	Diastolic dysfunction; LVOTO	Autosomal dominant — sarcomere protein mutations (MYH7, MYBPC3)	Most common cause of sudden cardiac death in young athletes
Restrictive (RCM)	Normal size but stiff walls; ↓ filling	Diastolic dysfunction	Amyloidosis, sarcoidosis, hemochromatosis, fibrosis	Normal EF; ↑ filling pressures

Q6. Classify valvular heart disease. Describe rheumatic heart disease.

A: Valvular disease = stenosis (obstruction) or regurgitation (incompetence/backflow) or both.

Rheumatic Heart Disease (RHD):

Follows Group A β-hemolytic Streptococcal (GAS) pharyngitis → autoimmune reaction
Antibodies against streptococcal M protein cross-react with cardiac proteins ("molecular mimicry")
Pancarditis = myocarditis + pericarditis + endocarditis

Pathology:

Aschoff bodies (pathognomonic) = foci of fibrinoid necrosis surrounded by activated macrophages (Aschoff cells / caterpillar cells) + lymphocytes
Mitral valve most commonly affected (96%) → stenosis (most common valvular lesion in RHD)
Mitral stenosis → left atrial dilation → pulmonary HTN → right heart failure
"Fish-mouth" / "Button-hole" deformity of mitral valve on gross
Verrucous endocarditis — small vegetations along line of closure

Sequence: RHD → Mitral stenosis (most common) → Left atrial dilation → Atrial fibrillation → Thrombus → Systemic embolism (stroke)

🏷️ SYSTEM 2: RESPIRATORY PATHOLOGY

Q7. Classify lung carcinoma. Compare the major types.

Classification (WHO 2021): Four major types:

Type	%	Smoking	Location	Key Features
Adenocarcinoma	50% (most common)	Moderate (also in non-smokers)	Peripheral	Most common in women, non-smokers, <45 yr; EGFR mutation (target: erlotinib/gefitinib); TTF-1+; Clara cell origin
Squamous cell carcinoma (SCC)	20%	Strong	Central (hilar)	Arises from bronchial mucosa after squamous metaplasia → dysplasia → CIS; cavitation common; PTHrP → hypercalcemia
Small cell carcinoma (SCLC)	15%	Strongest	Central	Most aggressive; neuroendocrine origin; ACTH/ADH secretion; Kulchitsky (oat) cells; never surgically resectable
Large cell carcinoma	2%	Strong	Peripheral	Undifferentiated; exclusion diagnosis; poor prognosis

Paraneoplastic syndromes:

SCC → PTHrP → hypercalcemia (most common)
SCLC → ACTH → Cushing syndrome; ADH → SIADH; anti-Hu antibodies → Lambert-Eaton syndrome
Carcinoid → Serotonin → carcinoid syndrome

Overall most common cause of cancer death in both men and women.

Source: Robbins & Kumar Basic Pathology

Q8. What is pneumonia? Compare lobar pneumonia vs. bronchopneumonia.

Feature	Lobar Pneumonia	Bronchopneumonia
Distribution	Entire lobe (or segment)	Patchy; multiple lobules; bilateral
Age	Young adults	Extremes of age (infants, elderly)
Common organisms	Streptococcus pneumoniae (most common)	S. aureus, H. influenzae, Klebsiella, E. coli, mixed
Consolidation	Homogeneous lobe consolidation	Patchy foci of consolidation
Exudate	Intraalveolar fibrinous exudate	Purulent intra-alveolar exudate

4 Stages of Lobar Pneumonia:

Congestion (Day 1-2) — vascular engorgement, edema fluid in alveoli, few bacteria
Red hepatization (Day 2-4) — alveoli packed with RBCs + neutrophils + fibrin; lung solid, red, liver-like
Grey hepatization (Day 4-8) — RBCs lysed; alveoli filled with neutrophils + fibrin; grey, firm
Resolution (Day 8+) — enzymatic digestion of exudate; macrophages clear debris; lung returns to normal

Q9. What is COPD? Compare emphysema and chronic bronchitis.

A: COPD = chronic airflow obstruction, mainly caused by smoking. Encompasses emphysema + chronic bronchitis.

Feature	Emphysema	Chronic Bronchitis
Definition	Permanent enlargement of airspaces distal to terminal bronchioles with destruction of walls	Productive cough for ≥3 months/year for ≥2 consecutive years
Pathology	Destruction of alveolar walls; loss of elastic recoil	Mucus gland hyperplasia in bronchi → ↑ Reid Index (gland/wall ratio >0.5)
Types	Centriacinar (smoking — upper lobe) / Panacinar (α1-antitrypsin deficiency — lower lobe)	-
"Pink puffer" vs "Blue bloater"	Pink puffer (maintain O₂ via ↑ respiratory effort, thin, barrel chest)	Blue bloater (cyanosis, edema, cor pulmonale, obese)
Pathogenesis	Protease-antiprotease imbalance: smoking → macrophages/neutrophils → elastase destroys alveolar walls	Smoking → mucus hypersecretion + ciliary dysfunction → infection → chronic inflammation

Q10. What is pulmonary embolism (PE)? What are the consequences?

Source: 95% from DVT of lower limbs.

Consequences depend on size:

Embolus size	Effect
Massive (>60% pulmonary circulation)	Sudden death, right heart failure (acute cor pulmonale)
Medium	Pulmonary infarction (hemorrhagic — triangular, pleural-based) — only if collateral circulation compromised
Small/multiple	Pulmonary hypertension (chronic)

Pulmonary infarct: Red (hemorrhagic) infarct — wedge-shaped, pleural-based, often with pleuritic chest pain + hemoptysis.

🏷️ SYSTEM 3: GASTROINTESTINAL PATHOLOGY (GIT)

Q11. Describe H. pylori gastritis. What is its role in peptic ulcer disease and cancer?

H. pylori (Helicobacter pylori): Gram-negative spiral rod; urease-positive. Found in gastric mucus.

Virulence factors (4 key features):

Flagella — motility through viscous mucus
Urease — converts urea → ammonia → neutralizes acid (protects bacteria, damages mucosa)
Adhesins — binds surface foveolar cells
Toxins (CagA, CagE) → IL-8 release → neutrophil chemotaxis → mucosal damage

Pathogenesis of PUD:

H. pylori in antrum
          ↓
Stimulates G cells → ↑ Gastrin → ↑ Acid secretion
          ↓
Antral gastritis → Peptic ulcer (duodenum > gastric)
          ↓ (if spreads to body)
Parietal cell loss → Gastric atrophy + Intestinal metaplasia
          ↓
Risk of Gastric Adenocarcinoma

H. pylori and Gastric MALT lymphoma:

Chronic inflammation → submucosal lymphoid aggregates (MALT)
MALT lymphoma develops; may regress with H. pylori eradication

H. pylori is classified as a Group I carcinogen (IARC).

Diagnosis: Urea breath test, stool antigen test, rapid urease test (biopsy), serology, histology (Giemsa stain).

Source: Robbins & Kumar Basic Pathology

Q12. What is ulcerative colitis (UC) vs. Crohn's disease (CD)? Compare.

Both are Inflammatory Bowel Diseases (IBD) — chronic idiopathic intestinal inflammation.

Feature	Ulcerative Colitis (UC)	Crohn's Disease (CD)
Location	Colon and rectum ONLY; rectum always involved	Any part of GIT (mouth to anus); terminal ileum most common
Distribution	Continuous (no skip lesions)	Skip lesions (patchy, discontinuous)
Inflammation depth	Mucosal only (superficial)	Transmural (full thickness)
Gross	Pseudopolyps, ulcers, "lead-pipe" colon	Cobblestone mucosa, fat wrapping, fistulas, strictures
Microscopy	Crypt abscesses (cryptitis), goblet cell depletion	Non-caseating granulomas (50%), lymphoid aggregates
Complications	Toxic megacolon, colorectal cancer (↑ risk with long-standing UC), hemorrhage	Fistulas, abscesses, strictures/obstruction, malabsorption
Extraintestinal	Pyoderma gangrenosum, primary sclerosing cholangitis	Erythema nodosum, uveitis, ankylosing spondylitis
Cancer risk	HIGH (colorectal carcinoma)	Slightly increased

Q13. What is hepatic cirrhosis? What are its causes and complications?

Cirrhosis = diffuse hepatic fibrosis with replacement of normal liver architecture by fibrous bands encircling nodules of regenerating hepatocytes. End-stage of most chronic liver diseases.

Causes:

Alcoholic liver disease (most common in West) — fatty liver → alcoholic hepatitis → cirrhosis
Viral hepatitis (HBV, HCV — most common in developing world)
Non-alcoholic fatty liver disease (NAFLD/NASH)
Biliary obstruction (primary biliary cirrhosis, sclerosing cholangitis)
Autoimmune hepatitis
Wilson's disease (copper accumulation), Hemochromatosis (iron accumulation)

Complications of cirrhosis:

                    CIRRHOSIS
                       │
          ┌────────────┼──────────────┐
          ↓            ↓              ↓
  PORTAL           HEPATO-         HEPATO-
HYPERTENSION      CELLULAR         CELLULAR
     │             FAILURE         CARCINOMA
     │
  ┌──┴────────────────────────────┐
  ↓         ↓          ↓          ↓
Splenomegaly Varices  Ascites  Caput medusae
(cytopenias) (esophageal → (SBP risk) (skin veins)
              hemorrhage)

Portal hypertension complications:

Esophageal varices → life-threatening hemorrhage (most dangerous complication)
Ascites → spontaneous bacterial peritonitis (SBP)
Splenomegaly → hypersplenism → pancytopenia
Hepatic encephalopathy → ↑ ammonia → CNS dysfunction
Hepatorenal syndrome

Hepatocellular failure: Jaundice, hypoalbuminemia (edema), coagulopathy (↓ clotting factors), spider angiomas, palmar erythema, gynecomastia, testicular atrophy, Dupuytren's contracture (in alcoholic).

Q14. What is the pathology of colorectal carcinoma (CRC)?

Most common GI malignancy (2nd leading cause of cancer death).

Precursor lesion: Adenomatous polyp (adenoma → carcinoma sequence)

Pathogenesis (APC/β-catenin pathway — "Vogelstein model"):

Normal colon
     ↓  APC loss (FAP gene)
Hyperproliferative epithelium
     ↓  KRAS mutation
Early adenoma
     ↓  DCC/SMAD loss
Intermediate adenoma
     ↓  TP53 loss
Late adenoma / Carcinoma in situ
     ↓  Additional changes
INVASIVE CARCINOMA → METASTASIS (liver first via portal vein)

Gross types:

Right colon — polypoid/exophytic, large, bleeds → iron-deficiency anemia
Left colon — annular/napkin-ring → obstruction, constipation/diarrhea alternation

Histology: Adenocarcinoma (gland-forming); mucin secreting; signet ring cell variant = poorly differentiated.

Lynch syndrome (HNPCC): Autosomal dominant; mismatch repair (MMR) gene mutations (MLH1, MSH2) → microsatellite instability (MSI); CRC + endometrial cancer risk.

🏷️ SYSTEM 4: RENAL PATHOLOGY

Q15. Compare nephrotic syndrome and nephritic syndrome.

Feature	Nephrotic Syndrome	Nephritic Syndrome
Pathology	↑ Glomerular permeability (podocyte/GBM damage)	Glomerular inflammation (proliferative)
Proteinuria	Massive (>3.5 g/day) - selective/non-selective	Mild-moderate (subnephrotic)
Hematuria	Absent or microscopic	Macroscopic hematuria (red cell casts)
Hypertension	Absent (or mild)	Present
Edema	Generalized (periorbital, pitting, ascites)	Mild
Hypoalbuminemia	Severe (<3 g/dL)	Mild
Hyperlipidemia	Yes (↑ hepatic synthesis)	No
Lipiduria	Yes (oval fat bodies, fatty casts)	No
GFR	Normal or slightly ↓	↓ (azotemia)

Causes of Nephrotic Syndrome:

Disease	Key Features	Microscopy
Minimal Change Disease (MCD)	Most common in children (90%); idiopathic; excellent response to steroids	LM normal; EM: podocyte foot process effacement
Membranous Nephropathy	Most common in adults; idiopathic (anti-PLA2R Ab) or secondary (SLE, HBV, drugs)	LM: GBM thickening; EM: subepithelial deposits; "spike and dome" pattern
Focal Segmental Glomerulosclerosis (FSGS)	Adults, HIV, heroin nephropathy, obesity	Focal (<50% glomeruli) segmental sclerosis; podocyte foot process effacement
Diabetic nephropathy	Kimmelstiel-Wilson nodules; diffuse glomerulosclerosis	Nodular mesangial expansion

Causes of Nephritic Syndrome:

Disease	Mechanism	Key Feature
Post-streptococcal GN	Type III hypersensitivity; subepithelial deposits	Hump-shaped subepithelial deposits; "lumpy bumpy" IF
Rapidly Progressive GN (RPGN/Crescentic GN)	Crescents in Bowman's space (parietal cell + macrophage proliferation)	Anti-GBM (Goodpasture), pauci-immune (ANCA), immune complex
IgA Nephropathy (Berger's disease)	IgA immune complexes in mesangium	Most common GN worldwide; hematuria with URTI
Lupus Nephritis (WHO class)	SLE; immune complex deposition	"Wire-loop" lesions; full house IF pattern

Source: Robbins & Kumar Basic Pathology

Q16. What is acute kidney injury (AKI)? What is the most common intrinsic cause?

AKI = rapid decline in GFR (hours-days) → oliguria/anuria + ↑ BUN + ↑ creatinine.

Classification:

Pre-renal AKI — ↓ renal perfusion (hypovolemia, shock, cardiac failure) — most common
Intrinsic AKI — renal parenchymal damage
Post-renal AKI — obstruction (stones, BPH, tumor)

Most common intrinsic cause: Acute Tubular Injury (ATI) (previously called Acute Tubular Necrosis/ATN)

Causes:

Ischemic ATI — shock, sepsis, surgery → tubular epithelial cell necrosis (especially PCT and medullary thick ascending limb)
Nephrotoxic ATI — aminoglycosides, cisplatin, radiocontrast, myoglobin (crush injury/rhabdomyolysis), hemoglobin

Morphology: Tubular cell death, tubular basement membrane disruption, cast formation (granular "muddy brown" casts), tubular dilatation.

Three phases of ATI:

Initiation phase — onset; oliguria begins
Maintenance phase — established oliguria (BUN/creatinine rise); lasts 1-2 weeks
Recovery phase — tubular regeneration; polyuria (tubules can't concentrate yet); recovery usually complete

🏷️ SYSTEM 5: HEMATOLOGY & LYMPH NODE PATHOLOGY

Q17. Classify leukemias. Compare acute vs. chronic leukemia.

Classification:

         LEUKEMIAS
         │
    ┌────┴──────┐
    ↓           ↓
  ACUTE       CHRONIC
    │           │
  ┌─┴──┐    ┌──┴──┐
  ↓    ↓    ↓     ↓
 ALL  AML  CLL   CML

Feature	Acute Leukemia	Chronic Leukemia
Cell differentiation	Blasts >20% (immature)	Mature appearing cells
Onset	Abrupt	Insidious
Prognosis	Rapidly fatal if untreated	Slower progression
Bone marrow	Packed with blasts	Hypercellular with mature forms
Peripheral blood	Many blasts	Mature lymphocytes (CLL) or mature granulocytes (CML)

ALL (Acute Lymphoblastic Leukemia): Most common cancer in children; lymphoblasts; t(12;21) most common in children (good prognosis); t(9;22) Philadelphia chromosome (poor prognosis); PAS positive blasts.

AML (Acute Myeloid Leukemia): Adults; myeloblasts with Auer rods (pathognomonic); t(15;17) in AML-M3 (APML) → ATRA therapy.

CML (Chronic Myeloid Leukemia): t(9;22) Philadelphia chromosome = BCR-ABL fusion gene → tyrosine kinase → uncontrolled proliferation; treated with imatinib; LAP score LOW (distinguishes from leukemoid reaction).

CLL (Chronic Lymphocytic Leukemia): Most common adult leukemia; CD5+ B cells; "smudge cells" on smear; small lymphocytic lymphoma = same disease.

Q18. Compare Hodgkin lymphoma (HL) vs. Non-Hodgkin lymphoma (NHL).

Feature	Hodgkin Lymphoma	Non-Hodgkin Lymphoma
Cell of origin	B cells (Reed-Sternberg cell)	B cells (85%) or T cells (15%)
Pathognomonic cell	Reed-Sternberg (RS) cell (owl-eye bilobed nuclei)	Depends on type
Spread	Contiguous node-to-node	Non-contiguous, widespread
Extranodal disease	Rare	Common
B symptoms	Fever, night sweats, weight loss	Less common
EBV association	Yes (especially mixed cellularity)	Burkitt lymphoma
Prognosis	Generally good (curable ~80-90%)	Variable

Hodgkin Lymphoma — Classification (WHO):

Nodular sclerosis — most common (60-70%); young women; nodular bands of fibrosis; lacunar RS cells; mediastinal mass
Mixed cellularity — second most common; EBV association; classic RS cells
Lymphocyte rich — best prognosis
Lymphocyte depleted — worst prognosis; older; many RS cells

NHL Important Types:

Diffuse Large B-cell Lymphoma (DLBCL) — most common NHL in adults; aggressive; BCL6 mutations
Follicular lymphoma — t(14;18) → BCL2 overexpression; indolent; CD10+; ↑ BCL2 = ↑ apoptosis resistance
Burkitt lymphoma — t(8;14) → MYC overexpression; "starry sky" pattern; jaw in African children (endemic); EBV+
Mantle cell lymphoma — t(11;14) → cyclin D1; aggressive

Q19. What is multiple myeloma? What are its features?

Multiple myeloma = malignant neoplasm of plasma cells producing monoclonal immunoglobulin (M protein).

Pathology:

Malignant plasma cells proliferate in bone marrow → replace normal marrow
Produce monoclonal Ig (IgG most common; IgA second)
Bence Jones protein = free light chains (κ or λ) excreted in urine

Clinical features (mnemonic: CRAB):

C = hypercalCemia (bone destruction → ↑ Ca²⁺) → polyuria, constipation, confusion
R = Renal failure (Bence Jones protein → cast nephropathy, light chain deposition)
A = Anemia (marrow replacement)
B = Bone pain / lesions ("punched-out" lytic lesions on X-ray; pathological fractures)

Additional features:

Recurrent infections (↓ normal Ig)
Rouleaux formation of RBCs on blood smear
↑ ESR, ↑ total protein, ↑ β2-microglobulin
"Rain-drop skull" on X-ray (punched-out lytic lesions)
Primary amyloidosis (AL type) in ~10%

Diagnosis:

Serum protein electrophoresis → M-spike (monoclonal band)
Bone marrow biopsy → >10% plasma cells
Urine Bence Jones protein (heat test — precipitates at 56°C, dissolves at 100°C)

🏷️ SYSTEM 6: ENDOCRINE PATHOLOGY

Q20. Compare Type 1 and Type 2 diabetes mellitus.

Feature	Type 1 DM (T1DM)	Type 2 DM (T2DM)
Onset	Childhood/adolescence (usually)	Adults (increasingly also children)
Body habitus	Normal weight or weight loss	Obese (80%)
Mechanism	Autoimmune destruction of β-cells → absolute insulin deficiency	Insulin resistance + relative β-cell failure
Insulin levels	Very low/absent	Elevated (early) → normal/low (late)
Autoantibodies	Anti-GAD65, anti-IA2, anti-Znt8 antibodies	None
HLA	HLA-DR3, DR4 (MHC class II)	No HLA linkage
Pathology	Insulitis (T-cell + macrophage infiltrate) → β-cell depletion + islet atrophy	Amyloid deposition in islets (IAPP); mild β-cell depletion
DKA risk	HIGH (no insulin → ketoacidosis)	Low; hyperosmolar non-ketotic coma more common
Treatment	Insulin required	Lifestyle → oral hypoglycemics → insulin

Complications of DM (common to both types):

DIABETES MELLITUS
        │
   ┌────┴────────────────────────────────────────┐
   ↓                                             ↓
MICROVASCULAR                           MACROVASCULAR
   │                                             │
   ├─ Diabetic nephropathy (Kimmelstiel-         ├─ Coronary artery disease
   │   Wilson nodules → ESRD)                    ├─ Stroke
   ├─ Diabetic retinopathy (leading cause        └─ Peripheral vascular disease
   │   of new blindness in adults)
   └─ Diabetic neuropathy (glove-stocking
       pattern; autonomic neuropathy)

Also: Diabetic foot (neuropathy + vascular disease + infection)
      Increased susceptibility to infections

Source: Robbins, Cotran & Kumar Pathologic Basis of Disease

Q21. What is Graves' disease? What are its features?

Graves' disease = most common cause of hyperthyroidism; autoimmune.

Mechanism: TSI (thyroid-stimulating immunoglobulins = IgG antibodies against TSH receptor) → continuously stimulate thyroid → ↑ T3/T4 production.

Pathology:

Diffuse hyperplasia of thyroid (diffuse goiter)
Tall follicular cells with papillary infolding
Colloid appears scalloped/pale ("moth-eaten")
Lymphocytic infiltration

Clinical triad:

Hyperthyroidism — weight loss, heat intolerance, tachycardia, tremor, ↑ BMR
Exophthalmos (proptosis) — lymphocytic infiltration + glycosaminoglycan deposition in orbital fat
Pretibial myxedema — thickening of skin over tibia (localized myxedema)

Key investigations: ↓ TSH, ↑ T3/T4, ↑ TSI, radioiodine uptake diffusely increased.

🏷️ SYSTEM 7: CNS PATHOLOGY

Q22. What are the types of intracranial hemorrhage? Compare.

Type	Artery/Vessel	Cause	Features
Extradural (Epidural)	Middle meningeal artery	Temporal bone fracture	Lucid interval then rapid deterioration; lens/biconvex hematoma on CT; ARTERIAL bleed
Subdural	Bridging cortical veins	Head injury (elderly, infants — shaken baby)	Crescent-shaped hematoma; no lucid interval; VENOUS bleed; slow accumulation
Subarachnoid	Berry (saccular) aneurysm (most common)	Spontaneous or trauma	"Worst headache of life"; blood in CSF (xanthochromia); Kernig's/Brudzinski's signs
Intracerebral (Intraparenchymal)	Cerebral vessels	Hypertension (most common)	Basal ganglia/internal capsule most common site; devastating

Berry aneurysm:

At branching points of Circle of Willis
Most common: junction of anterior communicating artery with ACA
Associated with polycystic kidney disease, coarctation of aorta, Marfan's syndrome

Q23. What is Alzheimer's disease? Describe its pathology.

Alzheimer's disease = most common cause of dementia in the elderly.

Pathology — 2 hallmark lesions:

Amyloid plaques (Senile/neuritic plaques):
- Extracellular deposits of Aβ (amyloid β-peptide) derived from APP (amyloid precursor protein)
- Core of amyloid surrounded by dystrophic (swollen) neurites and reactive astrocytes
- Congo red positive
Neurofibrillary tangles (NFTs):
- Intracellular bundles of hyperphosphorylated tau protein (normally stabilizes microtubules)
- Silver stain positive; "flame-shaped" in pyramidal neurons
- NFT burden correlates better with dementia severity than plaque count

Gross pathology:

Cortical atrophy (especially temporal, parietal, frontal lobes)
Widened sulci + narrowed gyri
Dilated ventricles (hydrocephalus ex vacuo)

Genetics: APP, PSEN1, PSEN2 mutations (early-onset familial); ApoE-ε4 allele = biggest genetic risk for sporadic late-onset; Down syndrome (trisomy 21) → early Alzheimer (extra copy of APP gene on chromosome 21)

🏷️ QUICK REFERENCE: SYSTEMIC PATHOLOGY HIGH-YIELD ONE-LINERS

Fact	Answer
Most common cause of MI	Left anterior descending (LAD) artery occlusion
Aschoff bodies are pathognomonic of	Rheumatic heart disease
Most common valvular lesion in RHD	Mitral stenosis
Heart failure cells (hemosiderin-laden macrophages) found in	Lungs (in left heart failure)
"Nutmeg liver" =	Right heart failure (centrilobular congestion)
Most common cause of sudden death in young athletes	Hypertrophic cardiomyopathy (HCM)
Most common primary lung tumor	Adenocarcinoma
Small cell carcinoma → ectopic ACTH →	Cushing syndrome
SCC of lung → PTHrP →	Hypercalcemia
Reid index >0.5	Chronic bronchitis
α1-antitrypsin deficiency →	Panacinar emphysema (lower lobes)
Most common cause of hepatic cirrhosis (West)	Alcoholic liver disease
H. pylori is Group I carcinogen →	Gastric adenocarcinoma + MALT lymphoma
Pseudopolyps in IBD	Ulcerative colitis
Skip lesions + transmural + granulomas	Crohn's disease
Kimmelstiel-Wilson nodules	Diabetic nephropathy
Foot process effacement only on EM	Minimal change disease (MCD)
"Starry sky" pattern on histology	Burkitt lymphoma
t(9;22) Philadelphia chromosome	CML (BCR-ABL); also ALL (poor prognosis)
t(14;18) → BCL2 overexpression	Follicular lymphoma
t(8;14) → MYC	Burkitt lymphoma
Auer rods	AML (myeloblasts)
Reed-Sternberg cells (owl eyes)	Hodgkin lymphoma
Most common HL subtype	Nodular sclerosis
M-spike on electrophoresis + lytic bone lesions	Multiple myeloma
Bence Jones protein	Free light chains in multiple myeloma
Berry aneurysm → worst headache of life	Subarachnoid hemorrhage
Lucid interval + temporal fracture	Extradural/Epidural hematoma
Amyloid plaques + NFTs	Alzheimer's disease
Tau hyperphosphorylation	Neurofibrillary tangles (Alzheimer's)
ApoE-ε4 allele	Sporadic Alzheimer's risk
Insulitis (T-cell infiltrate)	Type 1 DM
Amyloid in islets of Langerhans	Type 2 DM
TSI (anti-TSH receptor Ab)	Graves' disease

Sources: Robbins & Kumar Basic Pathology (10th ed.) and Robbins, Cotran & Kumar Pathologic Basis of Disease — accessed via the medical textbook library.

Make flashcards or mind maps of the high-yield one-liners from this guide

Asking for Preferences

Which format do you want? · How do you want the output?

Generating all mind maps and flashcard sets in parallel now!

Generating Image

A clean, colorful medical mind map on white background titled "CVS PATHOLOGY — High-Yield One-Liners". Central node: "CARDIOVASCULAR" in red circle. Six branches radiating out, each with bold label and answer text: Branch 1 (blue): "MI → Most common artery" → "LAD (Left Anterior Descending)". Branch 2 (green): "Aschoff bodies" → "Rheumatic Heart Disease". Branch 3 (orange): "Most common valvular lesion in RHD" → "Mitral Stenosis". Branch 4 (purple): "Heart failure cells in lungs" → "Hemosiderin-laden macrophages". Branch 5 (red): "Nutmeg liver" → "Right Heart Failure". Branch 6 (teal): "Sudden death in young athletes" → "Hypertrophic Cardiomyopathy (HCM)". Each branch has a small colored circle node. Arrows connect question to answer. Medical education style, clean sans-serif font, no clutter.

Generating Image

A clean, colorful medical mind map on white background titled "RESPIRATORY & GIT PATHOLOGY — High-Yield One-Liners". Central node: "RESP + GIT" in dark green circle. Eight branches: Branch 1 (blue): "Most common primary lung tumor" → "Adenocarcinoma". Branch 2 (red): "Small cell carcinoma + ectopic ACTH" → "Cushing Syndrome". Branch 3 (orange): "SCC lung + PTHrP" → "Hypercalcemia". Branch 4 (purple): "Reid Index >0.5" → "Chronic Bronchitis". Branch 5 (teal): "α1-antitrypsin deficiency" → "Panacinar emphysema (lower lobes)". Branch 6 (green): "Most common cause of cirrhosis (West)" → "Alcoholic liver disease". Branch 7 (pink): "H. pylori → Group I carcinogen" → "Gastric adenocarcinoma + MALT lymphoma". Branch 8 (brown): "Skip lesions + Transmural + Granulomas" → "Crohn's Disease". Each branch has bold question text and answer. Clean medical education diagram, white background, colored connecting lines.

Generating Image

A clean, colorful medical mind map on white background titled "RENAL & HEMATOLOGY PATHOLOGY — High-Yield One-Liners". Central node: "RENAL + HAEM" in dark blue circle. Eight branches radiating: Branch 1 (blue): "Kimmelstiel-Wilson nodules" → "Diabetic Nephropathy". Branch 2 (green): "Foot process effacement on EM ONLY" → "Minimal Change Disease (MCD)". Branch 3 (red): "Starry sky pattern" → "Burkitt Lymphoma". Branch 4 (orange): "t(9;22) Philadelphia chromosome" → "CML / ALL (poor prognosis)". Branch 5 (purple): "t(14;18) → BCL2 overexpression" → "Follicular Lymphoma". Branch 6 (teal): "t(8;14) → MYC" → "Burkitt Lymphoma". Branch 7 (pink): "Auer rods in blasts" → "AML". Branch 8 (brown): "Reed-Sternberg cells (owl-eye nuclei)" → "Hodgkin Lymphoma". Clean white background, medical education style, bold labels, colored branches with arrows.

Generating Image

A clean, colorful medical mind map on white background titled "NEOPLASIA, ENDOCRINE & CNS PATHOLOGY — High-Yield One-Liners". Central node: "NEOPLASIA + ENDO + CNS" in dark purple circle. Eight branches: Branch 1 (red): "Most common HL subtype" → "Nodular Sclerosis". Branch 2 (blue): "M-spike + lytic bone lesions" → "Multiple Myeloma". Branch 3 (green): "Bence Jones protein" → "Free light chains in myeloma". Branch 4 (orange): "Berry aneurysm → worst headache of life" → "Subarachnoid Hemorrhage". Branch 5 (purple): "Lucid interval + temporal fracture" → "Epidural Hematoma". Branch 6 (teal): "Amyloid plaques + NFTs" → "Alzheimer's Disease". Branch 7 (pink): "Insulitis (T-cell infiltrate in islets)" → "Type 1 DM". Branch 8 (brown): "Amyloid in islets + TSI antibodies" → "Type 2 DM / Graves' Disease". Bold text, clean sans-serif font, colored branches with small circle nodes, medical education style.

CVS drugs classification

Cardiovascular drugs are broadly classified by their therapeutic use: antihypertensives, antiarrhythmics, antianginals, heart failure drugs, antithrombotics, and lipid-lowering agents.

Searching sources...

Reading File

Finding Sources

Excellent — Goodman & Gilman and Katzung are both available. Let me search both simultaneously for CVS drug classifications.

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive content from Katzung and Goodman & Gilman. I have enough to deliver the complete CVS drug classification. Let me compile it now.

💊 CVS DRUGS — COMPLETE CLASSIFICATION

Sources: Katzung's Basic & Clinical Pharmacology (16th ed.) | Goodman & Gilman's Pharmacological Basis of Therapeutics | Braunwald's Heart Disease

🏷️ GROUP 1: ANTIHYPERTENSIVE DRUGS

Classification by Mechanism:

ANTIHYPERTENSIVE DRUGS
          │
    ┌─────┼──────────────────────────────────┐
    ↓     ↓         ↓           ↓            ↓
  DIUR-  RAAS     SYMPATH-   CALCIUM      DIRECT
 ETICS  DRUGS     OLYTICS    CHANNEL    VASODILATORS
                             BLOCKERS

A. DIURETICS

Class	Drugs	Mechanism	Use
Thiazides	Hydrochlorothiazide (HCTZ), Chlorthalidone, Indapamide	Block NaCl co-transporter in distal tubule	First-line HTN; mild HF
Loop diuretics	Furosemide, Bumetanide, Torsemide, Ethacrynic acid	Block Na-K-2Cl in thick ascending loop of Henle	Acute pulmonary edema, severe HF, hypercalcemia
K-sparing	Spironolactone, Eplerenone (aldosterone antagonists); Amiloride, Triamterene (ENaC blockers)	Block aldosterone receptor or ENaC	Hyperaldosteronism, HF (spironolactone reduces mortality), prevent K loss
Osmotic	Mannitol	Osmotic effect in tubule	Cerebral edema, raised ICP (not for HTN)
Carbonic anhydrase inhibitors	Acetazolamide	Block CA → ↓ H⁺/Na⁺ exchange	Glaucoma, altitude sickness (not primary HTN)

Mnemonic for loop diuretics: "BEEF" — Bumetanide, Ethacrynic acid, furosEmide, Furosemide (Lasix)

B. RAAS (Renin-Angiotensin-Aldosterone System) Drugs

Class	Drugs	Mechanism	Key Features
ACE Inhibitors (ACEi)	Captopril, Enalapril, Lisinopril, Ramipril, Perindopril	Block ACE → ↓ Angiotensin II + ↑ Bradykinin	1st line in DM nephropathy, HF, post-MI; SE: dry cough (bradykinin), angioedema, hyperkalemia
ARBs (AT1 blockers)	Losartan, Valsartan, Irbesartan, Candesartan, Olmesartan	Block AT1 receptor directly	Same indications as ACEi; no cough (no bradykinin ↑); preferred if ACEi cough
Direct Renin Inhibitor	Aliskiren	Block renin enzyme directly	Rarely used; avoid in pregnancy; CI with ACEi/ARB
Aldosterone Antagonists	Spironolactone, Eplerenone	Block mineralocorticoid receptor	HF (mortality benefit), hyperaldosteronism

ACEi mnemonic: "CELLAR PREP" — Captopril, Enalapril, Lisinopril, Lisinopril, Altace (Ramipril), Ramipril, Perindopril, Enalapril, Benazepril, Perindopril

C. SYMPATHOLYTICS

Class	Drugs	Mechanism	Notes
β-blockers (non-selective)	Propranolol, Nadolol, Timolol, Carvedilol (α+β)	Block β1 + β2 receptors	CI: asthma, COPD, peripheral vascular disease
β-blockers (selective β1)	Metoprolol, Atenolol, Bisoprolol, Nebivolol	Block β1 (cardioselective)	Preferred in asthmatics (relatively safe); Post-MI; HF
α1-blockers	Prazosin, Doxazosin, Terazosin	Block α1 → vasodilation	Hypertension + BPH; SE: first-dose syncope
Central α2 agonists	Clonidine, Methyldopa	Stimulate central α2 → ↓ sympathetic outflow	Methyldopa = safe in pregnancy; Clonidine: rebound HTN on abrupt withdrawal
Ganglionic blockers	Hexamethonium, Mecamylamine	Block nicotinic Nn receptors	Rarely used today
Adrenergic neuron blockers	Reserpine, Guanethidine	Deplete NE from nerve terminals	Rarely used; severe depression (reserpine)

D. CALCIUM CHANNEL BLOCKERS (CCBs)

Sub-class	Drugs	Selectivity	Uses
Dihydropyridines (DHPs)	Amlodipine, Nifedipine, Felodipine, Nimodipine, Nicar-dipine	Vascular smooth muscle >> cardiac	HTN, angina (Amlodipine = 1st line); Nimodipine = cerebral vasospasm after SAH
Non-DHPs	Verapamil (phenylalkylamine)	Heart > vessels	SVT, rate control in AF, angina; ↓ HR + contractility
Non-DHPs	Diltiazem (benzothiazepine)	Heart + vessels (intermediate)	SVT, AF rate control, angina

Memory trick:

"Nifedipine = Nipple" = vascular (peripheral) → used in HTN

Verapamil = "Very cardiac"

Diltiazem = in between

SE of CCBs: DHPs → reflex tachycardia, peripheral edema, flushing. Verapamil/Diltiazem → bradycardia, constipation (verapamil), heart block.

E. DIRECT VASODILATORS

Drug	Mechanism	Use	SE
Hydralazine	↑ cGMP → relaxes arterioles	Hypertensive emergency in pregnancy	Reflex tachycardia, lupus-like syndrome (SLE)
Minoxidil	Opens K⁺ channels → hyperpolarizes → vasodilation	Severe refractory HTN	Hypertrichosis (hair growth — topical use), fluid retention, tachycardia
Sodium nitroprusside	Releases NO → ↑ cGMP	Hypertensive crisis (IV)	Cyanide toxicity (contains CN⁻)
Diazoxide	Opens K⁺ channels	Hypertensive emergency; hypoglycemia	Hyperglycemia (blocks insulin release)

F. DRUGS FOR HYPERTENSIVE EMERGENCIES

Drug	Route	Use
Sodium nitroprusside	IV infusion	All hypertensive crises
Labetalol	IV	Hypertensive emergencies, aortic dissection
Nicardipine	IV	Hypertensive emergency + neuro patients
Hydralazine	IV/IM	Hypertension in pregnancy (eclampsia)
Methyldopa	Oral	HTN in pregnancy (chronic)

🏷️ GROUP 2: ANTIARRHYTHMIC DRUGS

Singh-Vaughan Williams Classification (Most Important for Exams)

CLASS I  →  Na⁺ Channel Blockers
CLASS II →  β-Blockers
CLASS III → K⁺ Channel Blockers (prolong APD)
CLASS IV  → Ca²⁺ Channel Blockers
+ MISC: Adenosine, Digoxin, Magnesium

CLASS I — Sodium Channel Blockers

Sub-class	Drugs	Action Potential	Kinetics	Uses
Class IA	Quinidine, Procainamide, Disopyramide	Prolongs APD & QT	Intermediate	AF, VT, WPW; Quinidine → "cinchonism" (tinnitus, headache); Disopyramide → anticholinergic SE
Class IB	Lidocaine, Mexiletine, Phenytoin	Shortens APD	Fast	Post-MI VT/VF (IV lidocaine); oral mexiletine for chronic VT
Class IC	Flecainide, Propafenone, Encainide	No change in APD	Slow	SVT, AF; proarrhythmic (CAST trial) — CI post-MI

Mnemonic Class IA: "Q-PD" — Quinidine, Procainamide, Disopyramide Mnemonic Class IB: "Likely MexPheny" — Lidocaine, Mexiletine, Phenytoin Mnemonic Class IC: "FPE" — Flecainide, Propafenone, Encainide

CLASS II — β-Blockers

Drugs	Use
Propranolol, Metoprolol, Atenolol, Esmolol (IV, ultra-short acting)	SVT, rate control in AF/atrial flutter, post-MI VT prevention, AVNRT

ECG effect: ↑ PR interval; ↓ HR Esmolol: IV, t½ = 9 min (used in perioperative/emergency)

CLASS III — Potassium Channel Blockers (Prolong APD/QT)

Drug	Key Features	Use
Amiodarone	Most powerful; all 4 classes; iodine-containing; longest t½ (40-55 days)	VT, VF, AF — drug of choice for most arrhythmias; SE: pulmonary fibrosis, thyroid (hypo/hyper), photosensitivity, corneal microdeposits, liver toxicity, grey-blue skin
Sotalol	β-blocker + Class III (prolongs QT)	AF, VT
Dronedarone	Amiodarone analog (no iodine, less toxic)	AF; CI in severe HF
Dofetilide	Pure IKr blocker; prolongs QT	AF cardioversion/maintenance
Ibutilide	IV only; prolongs QT	Acute AF/flutter cardioversion

CLASS IV — Calcium Channel Blockers (Non-DHP)

Drug	Use
Verapamil	AVNRT, SVT, rate control in AF — drug of choice for SVT
Diltiazem	SVT, AF rate control

ECG effect: ↑ PR interval (slows AV conduction)

MISCELLANEOUS ANTIARRHYTHMICS

Drug	Mechanism	Use	Notes
Adenosine	Activates A1 receptors → ↑ K⁺ → hyperpolarizes SA/AV node	Drug of choice for acute SVT/AVNRT (terminates)	IV bolus, t½ = 10 sec; SE: transient flushing, chest tightness, AV block
Digoxin	Na/K ATPase inhibitor → ↑ intracellular Ca²⁺ → positive inotropy; also vagomimetic → ↓ HR	Rate control in AF + HF	Narrow therapeutic index; toxicity: visual disturbances (yellow-green), nausea, arrhythmias
Magnesium sulphate	Blocks NMDA + Ca²⁺ channels	Torsades de Pointes (drug of choice), digitalis toxicity, eclampsia	IV infusion
Atropine	Muscarinic antagonist	Bradycardia, AV block	IV for acute bradycardia

🏷️ GROUP 3: ANTIANGINAL DRUGS

Three Drug Groups:

ANTIANGINAL DRUGS
       │
  ┌────┼────────────────────────┐
  ↓    ↓                        ↓
NITRATES  β-BLOCKERS    CALCIUM CHANNEL
                          BLOCKERS

Class	Drugs	Mechanism	Use
Organic Nitrates	GTN (nitroglycerin), Isosorbide dinitrate (ISDN), Isosorbide mononitrate (ISMN)	Donate NO → ↑ cGMP → venodilation (↓ preload) >> arterodilation (↓ afterload)	Acute angina (GTN sublingual), prophylaxis (ISMN long-acting)
β-blockers	Metoprolol, Atenolol, Propranolol	↓ HR, ↓ contractility → ↓ O₂ demand	Stable/unstable angina, post-MI
CCBs	Amlodipine (stable angina), Verapamil/Diltiazem (vasospastic angina)	Vasodilation, ↓ HR (non-DHP)	Stable angina, Prinzmetal/variant angina
Ranolazine	Blocks late Na⁺ current → ↓ intracellular Ca²⁺ → ↓ wall tension	Chronic angina (adjunct)	Does NOT lower BP or HR
Ivabradine	Blocks If (funny current) in SA node → ↓ HR without affecting contractility	Stable angina + HFrEF	Useful when β-blockers CI

Nitrate tolerance: Develops with continuous use; prevented by nitrate-free interval (8-12 hrs). GTN sublingual = onset 2 min, duration 30 min.

🏷️ GROUP 4: DRUGS USED IN HEART FAILURE

HEART FAILURE DRUGS
         │
    ┌────┼────────────────────────────┐
    ↓    ↓           ↓               ↓
  RAAS  DIUR-    β-BLOCKERS    POSITIVE
 DRUGS  ETICS              INOTROPES + 
                            OTHERS

Drug	Class	Mechanism	Mortality benefit?
ACE Inhibitors (Enalapril, Lisinopril)	RAAS	↓ Ang II, ↓ aldosterone, ↑ bradykinin → vasodilation + ↓ remodeling	YES
ARBs (Valsartan, Losartan)	RAAS	Block AT1	YES (when ACEi not tolerated)
Sacubitril/Valsartan (Entresto)	ARNi (ARB + Neprilysin inhibitor)	↑ BNP (vasodilatory) + ↓ AT1	YES (superior to ACEi)
Spironolactone / Eplerenone	Aldosterone antagonist	Block aldosterone → ↓ fibrosis + K-sparing	YES
Carvedilol, Metoprolol, Bisoprolol	β-blockers	↓ sympathetic activation → ↓ remodeling	YES
Furosemide	Loop diuretic	Relieve congestion (↓ preload)	Symptom relief only
Digoxin	Cardiac glycoside	Na/K ATPase inhibitor → ↑ Ca²⁺ → ↑ contractility; also ↑ vagal tone → ↓ HR	Reduces hospitalizations; NO mortality benefit
Ivabradine	If channel blocker	↓ HR	YES (in HFrEF with HR >70)
SGLT2 inhibitors (Dapagliflozin, Empagliflozin)	Glucose/sodium co-transporter	Osmotic diuresis + ↓ cardiac preload/afterload	YES (latest - major benefit)
Hydralazine + Nitrates	Vasodilators	↓ Preload + afterload	YES (in Black patients intolerant of ACEi)
Dobutamine	β1 agonist	↑ contractility	Acute decompensated HF (short-term IV)
Milrinone	PDE3 inhibitor	↑ cAMP → ↑ contractility + vasodilation	Acute HF, bridge to transplant

🏷️ GROUP 5: ANTITHROMBOTIC DRUGS

ANTITHROMBOTIC DRUGS
          │
    ┌─────┼─────────────┐
    ↓     ↓             ↓
ANTI-  ANTI-        THROMBO-
PLATE- COAG-         LYTICS
LETS   ULANTS

A. ANTIPLATELET DRUGS

Drug	Mechanism	Use
Aspirin	Irreversibly blocks COX-1 → ↓ TXA2	ACS, post-MI, stroke prevention; low dose 75-100 mg
Clopidogrel	Irreversibly blocks P2Y12 ADP receptor	ACS, PCI (stent), stroke; prodrug (CYP2C19 activation)
Ticagrelor	Reversibly blocks P2Y12 receptor	ACS (more potent than clopidogrel); direct acting
Prasugrel	Irreversibly blocks P2Y12	ACS + PCI; CI in prior TIA/stroke
Abciximab, Eptifibatide, Tirofiban	GP IIb/IIIa receptor blockers	ACS, PCI (IV use)
Dipyridamole	PDE inhibitor → ↑ cAMP; also adenosine uptake inhibitor	Stroke prevention (with aspirin = Aggrenox)

B. ANTICOAGULANTS

Drug	Mechanism	Route	Key Points
Unfractionated Heparin (UFH)	Activates antithrombin III → inhibits IIa (thrombin) + Xa	IV/SC	Monitor aPTT; antidote = Protamine sulphate; HIT (thrombocytopenia)
LMWH (Enoxaparin, Dalteparin)	Activates AT-III → mainly inhibits Xa	SC	More predictable; no monitoring needed; preferred in pregnancy; antidote = Protamine (partial)
Fondaparinux	Synthetic pentasaccharide; selectively inhibits Xa via AT-III	SC	No HIT risk; no antidote
Warfarin	Inhibits Vitamin K epoxide reductase → ↓ clotting factors II, VII, IX, X + protein C, S	Oral	Monitor PT/INR; antidote = Vitamin K (slow) or FFP (fast); many drug interactions
Dabigatran	Direct thrombin (IIa) inhibitor	Oral	DOAC; antidote = Idarucizumab; AF, DVT/PE
Rivaroxaban, Apixaban, Edoxaban	Direct factor Xa inhibitors	Oral	DOACs; antidote = Andexanet alfa; AF, DVT/PE, ACS

Warfarin vs. Heparin:

Heparin = parenteral, immediate onset, used in ACUTE settings

Warfarin = oral, delayed onset (3-5 days), used for CHRONIC anticoagulation

Bridge therapy = use both during transition

C. THROMBOLYTICS (FIBRINOLYTICS)

Drug	Mechanism	Use	SE
Streptokinase	Activates plasminogen → plasmin; antigenic (1st generation)	STEMI, DVT, PE	Allergic reactions, bleeding
Alteplase (tPA)	Recombinant tPA; fibrin-specific (2nd generation)	STEMI, ischemic stroke (within 4.5 hr), massive PE	Intracranial hemorrhage
Tenecteplase, Reteplase	Modified tPA; longer t½ (3rd generation)	STEMI (single IV bolus)	Bleeding

Antidote to thrombolytics: Aminocaproic acid (inhibits fibrinolysis)

🏷️ GROUP 6: LIPID-LOWERING DRUGS (ANTIHYPERLIPIDEMICS)

Class	Drugs	Mechanism	Effect	Use
Statins (HMG-CoA reductase inhibitors)	Atorvastatin, Rosuvastatin, Simvastatin, Pravastatin, Lovastatin	Block HMG-CoA reductase → ↓ cholesterol synthesis → ↑ LDL receptor expression	↓↓ LDL (primary), ↓ TG, ↑ HDL	1st line for hypercholesterolemia, atherosclerosis prevention; SE: myopathy/rhabdomyolysis, ↑ LFTs
PCSK9 inhibitors	Evolocumab, Alirocumab	Block PCSK9 → ↑ LDL receptor recycling → ↓ LDL	↓↓↓ LDL	Familial hypercholesterolemia, statin-intolerant patients
Fibrates	Fenofibrate, Gemfibrozil, Bezafibrate	Activate PPARα → ↑ lipoprotein lipase → ↑ TG clearance	↓↓ TG, ↑ HDL, ↓ LDL (modest)	Hypertriglyceridemia; SE: myopathy (↑ risk with statins)
Niacin (Nicotinic acid)	Inhibits lipolysis in adipose → ↓ VLDL → ↓ LDL + ↑ HDL	↑↑ HDL, ↓ TG, ↓ LDL	Now rarely used; SE: flushing (↓ by aspirin pretreatment), hyperglycemia, gout
Ezetimibe	Blocks NPC1L1 transporter → ↓ intestinal cholesterol absorption	↓ LDL (10-20%)	Used with statins; SE minimal
Bile acid sequestrants	Cholestyramine, Colestipol, Colesevelam	Bind bile acids in gut → ↑ bile acid synthesis → ↑ LDL receptor	↓ LDL	↑ TG (contraindicated in hypertriglyceridemia); SE: constipation, GI
Omega-3 fatty acids	Icosapentaenoic acid (EPA)	↓ VLDL synthesis	↓ TG	Severe hypertriglyceridemia

🏷️ QUICK SUMMARY TABLE — CVS DRUGS AT A GLANCE

Indication	Drug of Choice / First-Line
Hypertension (uncomplicated)	Thiazide / ACEi / ARB / Amlodipine
HTN + Diabetes / CKD	ACEi or ARB
HTN + Heart failure	ACEi + β-blocker + Aldosterone antagonist
HTN + Angina	β-blocker or CCB
HTN in pregnancy	Methyldopa (chronic), Hydralazine/Labetalol (acute)
Hypertensive crisis	Sodium nitroprusside IV
Acute MI (STEMI)	Aspirin + Clopidogrel + Thrombolysis / PCI
Stable angina	GTN (acute) + β-blocker (prophylaxis)
Prinzmetal/Vasospastic angina	CCB (Amlodipine); β-blockers contraindicated
Acute SVT	Adenosine IV (first-line)
AF rate control	β-blockers / Diltiazem / Verapamil / Digoxin
AF rhythm control	Amiodarone / Flecainide
VT/VF	Amiodarone (first-line antiarrhythmic)
Torsades de Pointes	IV Magnesium sulphate
Heart failure (HFrEF)	ACEi/ARBi + β-blocker + Aldosterone antagonist + SGLT2i
DVT/PE treatment (acute)	LMWH → DOAC (rivaroxaban/apixaban)
Long-term anticoagulation (AF)	DOAC (Dabigatran/Rivaroxaban/Apixaban) or Warfarin
Ischemic stroke (thrombolysis)	Alteplase (tPA) within 4.5 hrs
High LDL / Dyslipidemia	Statin (1st line always)
High Triglycerides	Fibrate or Omega-3
Familial hypercholesterolemia	High-dose statin + PCSK9 inhibitor

🏷️ KEY DRUG ANTIDOTES — CVS (Must Know!)

Drug	Antidote
Heparin (UFH/LMWH)	Protamine sulphate
Warfarin	Vitamin K (slow, 12-24 hrs) / FFP (immediate)
Dabigatran	Idarucizumab
Rivaroxaban / Apixaban	Andexanet alfa
Fibrinolytics (Streptokinase, tPA)	Aminocaproic acid
Digoxin toxicity	Digoxin-specific antibody fragments (Digibind)
Nitroprusside (cyanide toxicity)	Sodium thiosulfate + Hydroxocobalamin

Sources: Katzung's Basic & Clinical Pharmacology (16th ed.), Goodman & Gilman's Pharmacological Basis of Therapeutics — accessed via the medical textbook library.

This is a shared conversation. Sign in to Orris to start your own chat.